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Two T cells, alike in specificity 
In vivo and in vitro to describe 
From common sequence t’new affinity 
Where effects to increased kon ascribe  
 
From forth the thymi of transgenic mice 
The T cells develop with different ends. 
The one, too strong for peptide ends its life 
If it escapes responsiveness suspends. 
 
The weaker one proliferates in spades 
But responds to fewer altered peptides, 
A consequence of kinetic downgrades 
Though cell signaling is maintained inside. 
 
The differences twixt the T cells are clear 
The details of which are described in here.  
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ABSTRACT OF THE DISSERTATION 
The kinetics of TCR:pMHC interactions regulate CD4 T cell selection and activation 
By 
Jennifer N. Lynch 
Doctor of Philosophy in Immunology 
Washington University in St Louis, 2012 
Professor Paul M. Allen, Chairperson 
 
 
The T cell is a critical player in the adaptive immune response. T cells function by 
stimulating antibody production by B cells, secreting cytokines to attract other immune 
cells, regulating the response of other T cells, and directly killing infected or damaged 
targets. The role of the adaptive immune response depends on the specific recognition of 
foreign antigenic epitopes by the T cell.  
A T cell’s specificity for antigen is conferred by the T cell receptor (TCR). The 
TCR is designed to bind a peptide antigen presented on an MHC molecule by an antigen 
presenting cell (APC). The strength of this interaction is determined by the ratio of the 
rate of dissociation (koff) and the rate of association (kon) between the TCR and the 
pMHC. The overall affinity of the complex must be sufficient for productive transmission 
of signals through the TCR to activate a T cell. However, the precise regulation of this 
event is not fully understood. Structural changes are thought to occur once the TCR 
encounters pMHC. Because of the energetics involved, kinetic and thermodynamic 
parameters have been correlated with the pattern and strength of T cell activation but 
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these relationships do not explain all TCR:pMHC. The contact duration or dwell time of 
the TCR with pMHC takes into account the potential for rebinding events, which can 
enhance the signal strength and are related to the kon and koff of the complex. A faster kon 
can balance out a fast koff to have sufficient interaction between the TCR and pMHC for 
complete T cell activation. The kon also controls the number of rebinding events that can 
occur. Even so, the role of kon in T cell biology has not been explored independently of 
changes in koff.  
 Presented in this thesis is a system using two TCRs with specificity for the same 
antigen to compare how changes in kon alter T cell development and function. The n3.L2 
and a mutant version, M2, recognize the Hbd(64-76) antigen presented on the I-Ek MHC 
class II molecule. M2 had a 3.7 fold stronger affinity for Hb(64-76)/I-Ek due solely to a 
faster kon. As a consequence, the M2 TCR responded more strongly to a broader range of 
altered Hb peptide ligands (APLs). While this presumably was due to an overall 
increased association with the MHC molecule, which could result from increased kon, the 
M2 TCR still retained antigen specificity and did not respond strongly to all Hb APLs. 
N3.L2 hybridomas and double positive thymocytes responded more strongly to two APLs 
of the P2 TCR contact residue. Therefore the changes between the n3.L2 and M2 TCR 
structures only allow certain residues to productively bind. By measuring the kinetics of 
n3.L2 and M2 in association with APL/I-Ek, the maximal IL-2 response is accurately 
predicted by the koff. No kinetic parameter correlated with the amount of APL needed to 
stimulate IL-2 production, suggesting other factors may be involved. 
 Since the response to APLs can mimic the ability of a TCR to recognize selecting 
self-peptides in the thymus, peripheral T cell responsiveness may be developmentally 
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controlled. TCR transgenic mice were generated expressing either the n3.L2 or M2 TCR. 
M2 thymocytes had stronger recognition of endogenous peptides and were deleted 
through negative selection when exposed to Hb(64-76) as a self peptide. N3.L2 
thymocytes underwent full development and were not completely deleted by Hb(64-76). 
Interestingly, this difference in T cell selection led to functional consequences in 
peripheral T cells. Ca2+, an early activation signal, was more sustained in n3.L2 CD4 T 
cells and more oscillatory in M2 CD4 T cells. Interestingly, M2 CD4 T cells failed to 
proliferate in response to antigen. Therefore, the TCR sensitivity set during T cell 
selection leads to qualitatively different signaling cascades in the periphery and can 
generate an anergic population with increased kon for pMHC recognition. 
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CHAPTER 1 
 
Introduction 
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T cells are a critical component of the adaptive immune response. T cells develop in the 
thymus, producing the repertoire of effector cells that provides protection from the vast 
array of foreign infections. Each T cell maintains specificity for antigen as a consequence 
of rearrangement of the TCRα and β chains and therefore the main function of T cells is 
to propagate a specific immune response targeting detected antigens. CD4 T cells 
produce cytokines to help activate other immune cells, such as CD8 T cells and B cells. 
CD4 T cells can differentiate into a population of memory cells that maintain a quiescent 
but highly responsive state to protect the host upon reinfection. CD8 T cells have 
cytolytic properties to directly kill infected cells.  
Unlike B cells, which can undergo somatic hypermutation to generate B cell 
receptors of increased affinity, the TCR specificity and affinity for peptides is determined 
in the thymus by selection during T cell development. The TCR loci recombine V-(D)-J 
segments to sequentially generate the β and α chains of the TCR. Productive 
rearrangement of both chains leads to selection of T cells that bind self-peptides 
presented on MHC class I or II. The TCR affinity for pMHC regulates outcomes of T cell 
selection in the thymus and activation of T cells in the periphery (1-4). The affinity (KD) 
of the TCR:pMHC complex is regulated by the dissociation rate (koff) and association rate 
(kon). Agonist peptides induce full T cell activation through strong interactions with the 
TCR (3, 5). In the thymus, these highly responsive T cells can be deleted by negative 
selection. Weaker TCR:pMHC interactions can result in partial T cell activation (6) or 
anergy (7, 8), though positively selecting TCR:endogenous pMHC interactions are also 
of very low affinity (9).  
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Structural basis of TCR specificity and flexibility for recognition of pMHC 
TCR:pMHC complex formation needs to overcome a high activation threshold leading to 
T cell activation (1, 10-13). Subtle conformational changes are necessary to ensure a 
stable TCR:pMHC complex and productive signaling through the TCR (14-17). 
Therefore, this activation threshold is a result of the energetics of TCR:pMHC complex 
formation. It has been suggested that TCR:pMHC binding is entropically unfavorable 
while being enthalpically favorable as order is increased (12, 18). Recent data has altered 
this thinking, favoring instead an activation threshold based on the affinity of the 
interaction, where summation of the energy from individual amino acid interactions 
results in varying levels of T cell activation (19). The TCR:pMHC binding footprint is a 
specific but flexible structure (20) where CDRs 1, 2, and 3 of the TCR form contacts with 
the pMHC complex. TCRs have specificity for pMHC but also have the ability to 
recognize many different but closely related peptides. Inherent TCR flexibility is an 
effective mechanism for generating a sufficient T cell repertoire to target infections and 
tumors but can go awry generating autoimmunity (10, 21). Relatively large 
conformational changes have been described for the CDR3 regions, potentially resulting 
in stable peptide engagement (17, 22). However, it seems clear that another factor must 
be initiating the association and inducing the CDR3 conformational changes. 
TCR specificity for pMHC is encoded in the variable CDR loops, which form the 
binding footprint for TCR to contact the pMHC complex (23, 24). TCR specificity for 
MHC is maintained by interactions with CDRs 1 and 2 (25, 26). The germline encoded 
interaction between a TCR and an MHC is best defined for T cells using Vβ8.2 in which 
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a set of conserved of interactions exists between the TCR CDR1β and two tyrosine 
residues on the MHCβ chain (26-28). While CDRs 1 and 2 are highly conserved, 
introduction of mutations in these CDR loops can result in generation of high affinity 
TCRs (29, 30), potentially as a consequence of an optimal binding conformation or 
enhanced TCR:pMHC stability (16, 20, 25, 31, 32). The CDR1α region can stabilize the 
TCR and contribute energetically to the overall complex through contact with the MHC 
or by directly influencing the CDR3α contact with peptide (22, 32, 33). In the general 
diagonal orientation of the TCR on pMHC, the CDR3 loops position across the peptide 
binding groove providing direct interactions with specific amino acid side chains (17, 22, 
34, 35). Since the CDR3 loops interact with the peptide, conferring the cross-reactive 
property of T cells (36), they have been the main focus in determining what makes a T 
cell potentially autoreactive (37, 38). However, mutations in the CDR1 and 2 loops can 
generate a higher affinity TCR (29) that are potentially autorreactive.  
 
Components of TCR:pMHC association that determine T cell activation 
Through thermodynamic and kinetic studies, TCRs have generally been described as 
having slow association rates and fast dissociation rates (17, 39) compared to antibodies, 
leading to short windows for productive activation and signaling outcomes post TCR 
engagement. Some studies have found correlations between dissociation rate (koff) 
measurements and T cell activation (39-43), though activation cannot be reliably 
predicted based on koff alone (1, 12). Since structural changes occur when the TCR 
engages pMHC (1, 16, 17), the initial TCR:pMHC association is somewhat temperature 
dependent and thermodynamic measurements, such as heat capacity, can correlate with T 
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cell activity (12, 44, 45), especially when combined with koff. Because of the number of 
outliers with each model, there is no consensus for one parameter being a predictor of a 
peptide’s ability to stimulate a TCR (46).  
A few studies have suggested a role for kon. TCR mutants engineered in vitro for 
higher affinity resulted from a dominant association rate (kon) (1, 16). Recently, it was 
shown that a stimulatory pMHC with a very fast koff could compensate with a fast kon 
resulting in sufficient interaction between the TCR and pMHC for full activation (47, 48). 
Mutations that increase TCR kon also stabilize the TCR structure (16). T cells with 
increased kon and affinity would reflect a structure optimized to bind pMHC. In support 
of this theory, studies have implicated faster kon in better IFNγ-IFNγR interaction (49) 
and increased autoreactivity leading to spontaneous EAE pathogenesis (10). Faster kon 
would mimic the effect of slower koff, resulting in the same kinetic discrimination for T 
cell activation (2, 3). 
 
Models of productive T cell activation 
There are multiple models to explain how the association of TCR with specific pMHC 
complexes results in varying levels of T cell activation. Some evidence suggests the level 
of T cell activation may be a result of the inherent affinity of the TCR:pMHC complex, 
with increasing affinity leading to formation of more TCR:pMHC complexes and 
therefore stronger proliferation and cytokine production (46, 50). A large number of 
clusters of TCR:pMHC would result in sufficient phosphorylation of kinases proximal to 
the TCR to fully activate a T cell (51). Alternatively, a similar result can be achieved with 
multiple interactions between the TCR and either the same or neighboring pMHC (2, 43). 
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Serial triggering of a TCR leads to accumulation of signals the sum of which can 
overcome an activation threshold or increase the maximal response (4, 52). The 
frequency of rebinding can be driven by kon or koff. In both the affinity and serial 
triggering models, changes in the koff or kon would alter the outcome of activation, 
potentially resulting in partial activation of a T cell. Full T cell activation requires a 
sufficient length of contact between the TCR and pMHC to phosphorylate downstream 
signaling molecules (53-55). The density of TCR on a T cell or presented pMHC 
contributes to the overall contact time. Dual TCR T cells express lower levels of specific 
TCR and have decreased sensitivity and reduced responses to pMHC as a result (56). The 
contact duration or confinement time is proportional to the overall affinity and changes in 
kon and koff would alter the longevity of the TCR:pMHC complex (47, 48).The overall 
duration of TCR:pMHC takes into account the ability of receptors to rebind in addition to 
affinity, measuring the effective half-life for T cell activation. A high local concentration 
of TCR and pMHC enhances the likelihood of forming multiple productive or sustained 
interactions (57-59). In fact, a stronger correlation was observed between antigen potency 
and maximal efficacy when confinement time was taken into consideration with koff or 
KD and this relationship may have been more dependent on kon (43). 
Two possible structural mechanisms for TCR:pMHC interaction kinetics have 
been described. The first model is an induced-fit model where a ligand-induced 
conformational change results in stabilization of the initial complex and determines the 
association rate (1, 60). The rate can also be a function of the ligand’s structure, 
confirming how increasing affinity is possible. In this scenario, cross-reactive peptide 
recognition is maintained by TCR flexibility, though it is limited by selection. The 
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second model predicts the existence of multiple free-site conformers, which account for 
the TCR flexibility (16). The overall association rate would be controlled by the 
transition between these conformers of the TCR binding site and would explain 
crossreactivity of the TCR. Increased kon would reflect preferential conformations for 
TCR:pMHC binding.  
 
Caveats with previous studies of kon 
Previous studies have been unable to differentiate between the effect of increased kon and 
decreased koff as TCR modifications have resulted in changes to both kinetic parameters. 
Studies by Aleksic, et al. and Govern, et al. (47, 48) clearly revealed that changes in kon 
can affect the ability of a peptide to stimulate a T cell, but based their conclusions on 
TCR:pMHC combinations with changes in both kon and koff. Therefore, it remains 
important to understand the individual contribution kon makes in determining T cell 
selection and activation. Other studies have found no correlation between kon and 
increased affinity (40, 61) but these systems involved either large conformational changes 
(40) or did not measure any affinity maturation (61) and therefore would not observe the 
proposed affect. 
 
Stimulatory ability of different peptides 
The TCR recognizes structural features of amino acid side chains of specific peptides 
bound to MHC molecules (35). The sum of binding energetics between the TCR and 
pMHC dictate the overall affinity of the complex and determine how a T cell will 
respond to a specific peptide presented on MHC in both the thymus and periphery (19). 
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There are critical residues on these peptides for generating TCR recognition (62), but 
some modifications can maintain peptide potency. In addition to identification of 
naturally occurring stimulatory peptides, altered peptide ligands (APL), modified 
versions of agonist peptides, have been used to measure TCR flexibility and differential T 
cell activation. APLs are synthetically generated peptides with substitutions in TCR or 
MHC contact residues that potentially enhance or inhibit the formation of the 
TCR:pMHC complex. A peptide that induces full activation, both cytokine production 
and proliferation, is deemed an agonist. While multiple agonist ligands can be recognized 
by a single TCR, these peptides may have little sequence or structural homology (63). A 
second tier of peptides consists of partial agonists that activate T cells to varying degrees. 
Partial agonists may induce lower levels of cytokine production or proliferation but also 
can result in entirely distinct signaling patterns from cognate antigen (6, 42, 64). Peptides 
with a lower potency than partial agonists can inhibit T cell activation in response to 
agonists (65). These antagonists are unable to stimulate T cell function but may be 
important for thymic selection of T cells.  
 
TCR:pMHC affinity regulates T cell development 
T cell development results in death by neglect, death by negative selection, or life by 
positive selection (66). There is an affinity continuum of a TCR for endogenous pMHC 
that regulates selection of T cells in the thymus (67). For T cells to be selected, the TCR 
must have sufficient affinity for endogenous pMHC above the threshold for positive 
selection but below the threshold for negative selection (9, 68, 69). T cells on the low end 
of the affinity spectrum have insufficient recognition of pMHC and die from neglect (70). 
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An entire population of T cells must be selected by a potentially small number of 
different self-peptides. In mice expressing a single pMHC in the thymus, a large and 
diverse repertoire of T cells develops (71). These studies suggest preselection T cells may 
favor contact with the MHC molecule but are selected for peptide specificity during 
negative selection (23, 72). This specificity is retained in peripheral activation, a key 
feature of T cell reactivity. 
 
Low affinity TCR:pMHC interaction leads to positive selection 
Positively selecting peptides are highly specific and do not reflect the structural features 
of agonists (70, 73-75). Positive selection has an analog threshold due to partial or low 
levels of T cell activation (76). Positive selection has been induced using low affinity 
APLs, which mimic the affinity of self-peptides in the thymus (68, 73, 77). Naturally 
occurring selecting peptides have being identified for CD8+ (9, 75) and CD4+ T cells (74). 
These peptides are not agonist peptides for T cell activation and proliferation in the 
periphery but instead are lower affinity peptides that usually function as weak agonists or 
antagonists. The role of peptide strength in selection was assessed in vivo by generation 
of mice expressing chimeric APL Hb–HEL transgenes on H-2k. Using APLs of various 
strengths, Williams et al. (78) dissected the ability of strong agonists, weak agonists, and 
null peptides to induce negative and positive selection. Antagonists, a null peptide, and 
weak agonists induced positive selection at low concentrations and negative selection at 
higher concentrations. Similar findings have been reported in other studies (9, 79). It was 
also thought that the amount of peptide and MHC on the surface, and consequently the 
amount of TCR, would be a determinant of positive selection (80). Kersh et al. (79) 
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assessed the levels of pMHC required for selection. By reducing the I-Ek expression 
using crosses of H-2k mice to H-2b haplotype, levels of specific TCR expression in the 
periphery decreased. Therefore, specific levels of pMHC are required to provide 
sufficient niches for efficient positive selection and transgenic TCR expression. As the T 
cells examined expressed multiple α chains, it could be that selection worked through 
one TCR efficient for selection and a second, self-restricted TCR could be activated in 
the periphery post selection, leading to autoimmunity.  
Additionally, TCR coreceptors might regulate positive selection. Using a 
positively selecting ligand, Jameson et al. (70) found that CD8 levels were decreased on 
selected T cells. By blocking CD8, they altered T cell clones’ abilities to respond to 
peptides, resulting in weak agonists functioning as antagonists. The coreceptor modulates 
the ability of a T cell to respond to peptide and therefore down modulation of CD8 could 
dampen reactivity to selecting self-peptides, as proposed in the “quantitative instructive” 
model (66). In the absence of CD4, positive selection of T cells is maintained by addition 
of antagonist APLs, which would induce negative selection in the presence of CD4 (81). 
Lack of CD4 did not skew the T cell repertoire towards CD8 but did indicate that higher 
affinity TCR:pMHC interactions are required for T cell development in the absence of 
coreceptors. Positive selection efficiency may be a result of other signaling molecules 
immediately downstream of the TCR, including CD3 subunits. CD3δ knockout mice 
have a developmental block at the double positive stage, prior to positive selection (82). 
Knocking-out the CD3ζ chain led to defective positive and negative selection, indicating 
that signal amplification through the TCR controls selection (83). A recent paper from 
our lab has established that decreased signaling through the TCR in PKCθ -/- mice also 
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led to inefficient positive selection (84).  Therefore, peripheral T cell populations are 
selected by lower signal strength through the TCR in response to self-peptide, confirming 
the continuum of peptide affinity versus selection.  
 
Negative selection of high affinity TCRs 
High affinity recognition of self-peptide MHC can result in negative selection. High 
affinity TCR:pMHC interactions have a longer contact time leading to increased 
signaling through the TCR (78). By increasing the affinity of the TCR for self pMHC 
complexes, peptides which were low affinity, inducing positive selection, would have 
high enough affinity to overcome the threshold for negative selection. TCRs that can 
respond to multiple peptides are equally more likely to be eliminated by negative 
selection (85, 86). Negative selection is a digital response due to the accumulation of 
specific signals downstream of the TCR (87), resulting in apoptosis of high affinity T 
cells to generate central tolerance (77, 78). Two potential models can explain 
development of a signal strong enough to induce negative selection. First, the TCR may 
have a high affinity for a selecting pMHC in the thymus. Second, accumulated signals as 
a result of multiple interactions with different pMHC complexes can lead to negative 
selection.  
Negative selection ensures central tolerance by elimination of self-reactive T cells 
from the repertoire, preventing autoimmunity upon T cell egress to peripheral lymphatic 
tissues. While positive selection occurs in the thymus medulla and results in pro survival 
signals, negative selection occurs in response to contact with cortical epithelial cells and 
results in apoptotic signals (88, 89). Initial studies of negative selection and central 
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tolerance were conducted by examining transplantation (90). Thymic grafts suggested 
that the thymus controlled the fate of T cell development, inducing tolerance to antigen 
due to restriction of T cell specificity. Kappler and Marack definitively proved that 
negative selection occurs at the transition from the double positive thymocyte state to the 
naive single positive thymocyte through elimination of specific subsets of T cells by 
specific self antigens (90, 91).  
However, the efficiency of negative selection is variable and some autoreactive T 
cells can enter the periphery, potentially leading to disease development. High affinity 
TCRs that escape negative selection are potentially selected using different binding 
conformations from those used for recognition of antigen in the periphery (92). It is 
suggested that low levels of some antigens in the thymus can result in elimination of only 
the highest affinity T cells, allowing lower affinity T cells to escape selection.  As 
selecting antigens are limited in the thymus, complete elimination of high affinity TCRs 
can be achieved in transgenic mice with small thymocyte populations (93, 94).  
 
Regulation of T cell activation by TCR:pMHC  
The functional ability of T cells is a reflection of stimulation through the TCR and 
costimulatory molecules. Complete T cell activation is the result of productive signaling 
through the TCR resulting in full phosphorylation of the TCR/CD3 complex and 
activation of ZAP-70. The kinetics of TCR:pMHC binding regulate whether full T cell 
activation occurs and the level of phosphorylation (95). Fast dissociation would result in 
incomplete activation (2, 3) and could be a mechanism of antagonism. Some ligands are 
able to activate, partially activate, or inhibit activation of a T cell (64). There are 
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measurable differences in downstream signaling factors from each of these ligand classes. 
TCR clustering can enhance signaling either by producing longer TCR:pMHC contacts or 
by increasing the rate of serial ligation and triggering (4, 96). The actin cytoskeleton of a 
T cell arranges to form and maintain contact with an APC necessary for sustained 
signaling and formation of new or rebinding TCR:pMHC complexes (97). A high density 
of pMHC may be required to activate rather than suppress T cell response (98). However, 
the quality of the peptide has a stronger effect on the response of a T cell. Low levels of 
strong agonist peptides are more able to stimulate IL-2 production than high levels of 
weak agonist in vivo (99), though agonists can induce anergy if very few pMHC 
compexes are engaged by a TCR (98). Affinity matured human TCRs lose sensitivity to 
low density of agonists but are able to respond to weak agonists (100). T cells with 
affinity at the high end of the normal spectrum maintain high sensitivity and recognize 
low affinity APLs (100).  
Formation of microclusters of TCR:pMHC quickly after contact generates an 
environment for signaling downstream of the TCR (101). These microclusters are 
continuously being generated to sustain signaling (101) but can fuse into larger structures 
with reduced signaling capacity (102). When the adhesion molecule ICAM-1 binds LFA-
1, recruitment of costimulatory and signaling intermediates to the site of TCR:pMHC 
contact can alternatively result in formation of the highly organized immune synapse 
(103, 104). The synapse is an adaptive controller of immune responses depending on the 
strength of the TCR:pMHC interaction, enhancing weak signals and degrading strong 
responses. The CD3 and CD4 coreceptors augment weak TCR signaling (105-107). 
Accumulation of CD3, CD4 and costimulatory molecules, such as CD28, leads to 
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amplification of initial signals through the TCR leading to the overall determination of T 
cell activation and function. 
 
Ca2+ signaling  
Intracellular signaling molecules differ in level and state according to levels of initial 
TCR signaling (108). One of the first biochemical responses upon TCR signaling is 
calcium (Ca2+) influx. Variation in activation and differentiation state of T cells produces 
unique Ca2+ flux signatures that can be measured by imaging with Ca2+ indicator dyes. 
Strong agonist peptides induce Ca2+ influx with a high initial peak followed by increased 
sustained intracellular Ca2+ levels (64). Weaker agonist peptides will produce lesser 
initial influxes and lower sustained levels, though still result in activation. Ca2+ flux 
changes have also been seen due to peptide concentration (109) and APL strength (110), 
strengthening the link between TCR:pMHC affinity and Ca2+ signaling. Complete T cell 
activation is achieved based on regulation of Ca2+ store release and influx by TCR signal 
strength. This signal can further be regulated based on timing of sustained signaling 
through synapse formation and receptor downregulation. 
 
IL-2 production 
IL-2 is critical for development and proliferation of T cells. The level of IL-2 production 
by activated T cells depends on costimulation (111, 112). Upon activation, a T cell 
expresses a high affinity version of the IL-2 receptor making it more sensitive to the 
presence of IL-2.   When a T cell is anergized, IL-2 secretion is suppressed whereas 
release of other cytokines may be maintained (113). Addition of IL-2 to anergized cells 
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overcomes the inhibitory signals, leading to T cell proliferation and further production of 
cytokines. Interestingly, IL-2 promotes the generation of high affinity regulatory T cells 
(Tregs) and therefore can function as an enhancer and inhibitor of T cell response (114).  
 
Limiting and inhibiting T cell activation 
There is a delicate balance, however, between heightened activation and over 
responsiveness to antigen. A hyperresponsive T cell can lead to inappropriate recognition 
of self-peptides resulting in autoimmune disease. Mechanisms have been built in to T cell 
machinery that finely regulate activation. In addition to stimulation through the TCR and 
coreceptors CD4/CD8 and CD3, costimulatory molecules on the surface of the TCR bind 
ligands on the APC activating new signaling cascades. Engagement of B7-1 and B7-2 on 
an APC by CD28 is thought to be important in driving T cell proliferation, cytokine 
production, and survival through regulation of Bcl-XL (112, 115, 116). CD28 has found 
to induce stabilization of IL-2 mRNA, leading to sustained T cell proliferation and 
responsiveness (112). Competing with CD28 for access to B7-1 and B7-2 is CTLA-4, 
primarily described as an inhibitor of T cell activation. CTLA-4 can block 
phosphorylation of Zap-70 suppressing proximal signals through the TCR complex (117). 
While CTLA-4 may contribute to a hypoproliferative T cell response by blocking IL-2 
production, it is not required for the induction of anergy as T cells deficient in CTLA-4 
will be hyperproliferative in response to chronic exposure to antigen and then enter into a 
state of anergy (118). CTLA-4 and PD-1 are both upregulated on T cells following 
activation through the TCR:pMHC complex. PD-1 also functions to limit T cell 
responsiveness but increased IL-2 overcomes PD-1’s suppressive effect through 
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activation of STAT5 (111). While many pathways of activation and suppression exist in a 
T cell, the balance of these signals and the influence of the surrounding milleu dictate the 
level of T cell response.   
 
How T cell selection influences activation, autoimmunity, and tolerance 
A complex set of distinct signals regulates positive and negative selection (76, 119), 
tuning T cell responsiveness in the periphery. Sustained signaling through ERK leads to 
positive selection of thymocytes whereas transient signaling results in negative selection 
(120, 121). Negative selection is an incomplete process and some high affinity T cells 
escape to the periphery where they can cause autoimmune disease (122). To prevent 
autoimmunity, potentially autorreactive T cells are either rendered unresponsive to 
antigenic stimulation (123) or deleted in the periphery to maintain peripheral tolerance 
(78). Because of the dual role of T cell affinity in selection and activation, the propensity 
for T cells to undergo tolerance may be set in the thymus by the affinity of the expressed 
TCR for self pMHC (124).  
Anergy, a state of hyporesponsiveness characterized by low IL-2 production and 
inhibited proliferation (123), has been induced in naive T cells through lack of 
costimulation (125, 126), exposure to APLs (6, 8, 77), sustained exposure to antigen 
(127), or low stimulation through the TCR as a result of either low affinity interactions 
(86, 128, 129) or unstable pMHC complexes (128). Activation following suboptimal 
stimulation, such as in the absence of costimulation or with high immunosuppressive 
signals, results in a phenotype akin to anergy. Anergized T cells downregulate TCR and 
costimulatory receptors to maintain the hyporeactive state (130). Rechallenge with an 
17 
agonist after anergy induction by APL stimulation leads to an inability to proliferate but 
restored IL-2 production both in vitro and in vivo (124). Weak agonist TCR:pMHC 
interactions, such as is measured with some APLs, often result in incomplete T cell 
activation and induction of anergy(5, 6, 8, 110, 131-133). However these mid affinity 
APLs may maximize T cell function in vivo where a high affinity interaction can lead to 
an attenuated T cell response by altering intracellular signaling (134).  
 
Hb as a model antigen used in the presented studies 
Hemoglobin is a self-protein found intracellularly or bound to haptoglobin, not free in 
circulation. Hb/Ek complexes have been found on all APCs, including in the thymus 
(135). In the mouse, the Hb protein exists in two naturally occurring allelic variants, Hbd 
and Hbs, such that T cells developing normally in Hbs strains can be reactive to cells from 
Hbd mice. The Hb system is ideal for examining T cell selection and activation 
consequences as T cells can be exposed to Hb peptide as a foreign or endogenous 
antigen.  
 
The n3.L2 system  
A series of T cell clones and hybridomas were originally generated against the β chain of 
the Hbd allelic variant and restricted to H-2k(135, 136) with dominant reactivity to the 
Hb(64-76) peptide (GKKVITAFNEGLK).  One T cell clone that has been used 
extensively in studies of the Hb model antigen was designated as 3.L2. The 3.L2 T cell 
receptor is composed of rearranged Vα18 and Vβ8.3 chains. 3.L2 specifically recognizes 
the Hbd(64-76) peptide presented on I-Ek (62) and is not reactive to the Hbs variant. 3.L2 
18 
was identified as a Th1 clone and its specificity has been examined with a panel of 
Hbd(64-76) altered peptide ligands.  
Early studies with Hb(64-76) reactive TCRs identified key peptide amino acid 
residues that were TCR or MHC contact residues. The TCRs were specific for the pMHC 
complex as mutagenesis of the primary contact residue, N72, and secondary TCR contact 
residues resulted in decreased proliferation (62). Some amino acid substitutions in the 
peptide could maintain T cell activation, identifying a range of permissible alterations of 
secondary TCR contact residues (63). Therefore, while the naturally occurring TCR was 
specific for the Hb(64-76) peptide on I-Ek, the TCR exhibited flexibility and could 
productively recognize altered peptides. To test the breadth of T cell flexibility, a panel of 
altered peptide ligands (APLs) was synthesized where select amino acids were 
substituted into the P2, P3, P5 or P8 peptide positions, which contact the TCR. These 
APLs were used to identify the phenomenon of TCR antagonism and characterize T cell 
recognition of ligands of varying potency (8, 42, 65).  
The cloned 3.L2 TCR was used to generate a TCR transgenic mouse (79). When 
the original 3.L2 TCR transgenic mouse was crossed to a Rag1-/- background, transgenic 
CD4 T cells failed to develop. It was identified that a mutation had been introduced into 
the transgenes and therefore the mouse was regenerated and named n3.L2. n3.L2 T cells 
developed in the presence of H-2k on a C57BL/6J Rag1-/- background. The presence of 
n3.L2 T cells was measured by a monoclonal antibody specific for the n3.L2 TCR 
clonotype, CAb. In the H-2k/k mice, approximately 6% of thymocytes were CD4+ T cells 
that expressed the n3.L2 receptor, though the level of positive selection was dependent on 
I-Ek expression levels, as reducing the amount of I-Ek in the thymus reduced the number 
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of CAb+ T cells (79).  In the peripehery, the majority of CD4+ T cells expressed the 
transgenic receptor with a second endogenous TCR. While dual TCR expression occurred 
on CD4+ T cells, the n3.L2 transgenic TCR was the dominant TCR undergoing positive 
selection. Therefore, this system provides a method to examine positive and negative 
selection of a CD4+ skewed TCR of known affinity.   
The n3.L2 model antigen system has been extensively used to understand T cell 
biology. From the initial studies of selection, it has been used to generate and characterize 
a series of Hb(64-76) altered peptide ligands (APLs) (35, 42) and describe the 
immunological synapse (103). Transgenic mice expressing APLs attached to membrane-
bound HEL were generated and crossed to the n3.L2 transgenic mouse to measure 
selection by APLs (78). The breadth of n3.L2 flexibility was tested in response to the 
panel of Hb(64-76) APLs by determining the EC50 of an IL-2 production assay. 
Correlations between APL stimulatory ability (agonist, antagonist, or null) and TCR 
binding kinetics were determined, permitting the first association between TCR:pMHC 
association and selection outcome in vivo. 
 
Generation of higher affinity n3.L2 mutants 
Extending upon these studies of n3.L2, a series of n3.L2 TCR mutants was generated to 
create high affinity receptors specific for the Hb(64-76) peptide (137, 138). Using the 
n3.L2 TCR sequence, a single chain TCR construct was generated. This scTCR was 
expressed on a yeast display system and used as the template for directed PCR 
mutagenesis to generate stable TCR mutants (139). Mutants with increased stability were 
detected on the surface of the yeast by labeling with CAb, a clonotypic antibody specific 
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for the n3.L2 TCR. After the first round of mutagenesis to generate a stably expressed 
n3.L2 TCR, two clones were identified with mutations in the TCRα and β chains. Since 
these two clones had moderately increased labeling by CAb, they were used as the 
templates for a second round of mutagenesis followed by selection with CAb. One of 
these clones that had the highest labeling by CAb was named M2. M2 expressed two 
mutations in CDR1α in addition to the stabilization mutations from the first round of 
mutagenesis. M2 was used as the template for generation of a library of affinity matured 
n3.L2 mutants selected by binding to the Hb/I-Ek Ig dimer. After multiple rounds of 
mutagenesis, a panel of n3.L2 mutants was generated with mutations in the CDR1α and 
CDR3α and β regions. M5 and M15 contain the M2 CDR1α mutations in addition to 
mutations in CDR3s. M4 and M14 have reverted forms of CDR1α, matching the 
wildtype n3.L2 TCR, but have the same CDR3 mutations as M5 and M15, respectively. 
This full panel permits the examination of each set of mutations separately and in 
combination to determine how alterations in one CDR loop affect TCR affinity and 
peptide specificity. Interestingly, the majority of changes in TCR reactivity and affinity 
that have been reported using various T cell sytems focus on differences in the CDR3 
loops. The unique changes in CDR1 resulting in the M2 TCR set up a system to 
specifically examine changes in the TCR structure that do not specifically contact the 
peptide surface. Surface plasmon resonance (SPR) analysis of scTCR constructs of all the 
mutants revealed a range of increased affinity for binding immobilized Hb/I-Ek. M2 had 
an affinity of 4.5µM. M4 and M5 had approximately 10-fold stronger affinity (580nM 
and 159nM, respectively). M15 was a full 800-fold increase over the wildtype n3.L2 
affinity for Hb/I-Ek, with a 25nM affinity. 
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Conclusions from previous studies using M4 and M15 mutants 
After generation of the n3.L2 high affinity mutants, M4 and M15 TCRs were expressed 
in hybridomas and used to further characterize TCR peptide specificity. M4 and M15 did 
not have increased sensitivity to wildtype Hb(64-76) (137, 140). A full panel of Hb(64-
76) APLs was then developed where each of the standard amino acids was singly 
substituted in to TCR contact sites, P2, P3, P5 and P8, on the Hb(64-76) peptide. n3.L2, 
M4, and M15 were screened against the entire Hb(64-76) APL panel to examine 
specificity and degeneracy of peptide recognition. n3.L2 responded to a limited pool of 
APLs, maintaining remarkable specificity. Because of increased affinity, M4 and M15 
exhibited broader recognition of APLs, with M15 recognizing the majority of APLs at 
each position including weak n3.L2 ligands (138). M15, which had mutations in CDR3β 
that were not present for M4, reacted to many more APLs, suggesting that while 
specificity is maintained by TCR contact residues, alterations in the CDR3 regions can 
drastically change peptide specificity. Thus, increased TCR affinity for pMHC led to a 
broader spectrum of allowable amino acids at TCR contact residues.  
While providing insight into the sensitivity of a high affinity TCR for pMHC, 
these studies were only conducted in vitro and failed to answer questions about how 
kinetics of TCR:pMHC regulate the response of a naturally selected T cell. Additionally, 
the increased affinities of M4 and M15 were due to changes in both the kon and koff. 
Therefore, the question of kon’s contribution in selection and activation of T cells 
remains.  
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M2 TCR: a system to study the effect of kon in vitro and in vivo 
The M2 TCR variant differed from the wildtype n3.L2 TCR by two amino acid changes 
in the CDR1α region, a lysine to glutamic acid at residue 25 and a threonine to serine 
mutation at residue 28. These two mutations resulted in a 3.7 fold higher affinity due 
specifically to a faster kon. Therefore, M2 provides a unique system to investigate how 
alterations in TCR kon affect T cell biology. Neither the Glu25 nor Ser28 in the CDR1α 
loop directly contact the pMHC (based on a crystal structure of M15:Hb(64-76)/I-Ek by 
T. Brett and D. Fremont) and therefore must be affecting the TCR affinity in another 
way. Glu25 is a charge reversal mutation whose side-chain is completely solvent exposed 
and distant from the pMHC interface.  In contrast, Ser28 is buried within the Vα domain 
with its hydroxyl group forming a hydrogen bond to the backbone of Thr26 of the α 
chain. Importantly, the two CDR1α residues flanking Ser28, Try27α and Thr29α, 
directly contact the pMHC.  Thus, while the Ser28 mutation does not directly contact I-Ek 
or Hb, it nonethless could enhance binding by providing an advantageous conformation 
that would rapidly associate with the pMHC.   
Like changes in koff, kon could regulate activation and selection of T cells 
potentially by altering the overall dwell time of the TCR with endogenous and foreign 
pMHC. As the affect of kon has not previously been isolated, comparison of n3.L2 and 
M2 is a novel system to examine how the kon of the TCR binding pMHC regulates T cell 
selection and activation. Since the measured affinity of M2 for Hb(64-76)/I-Ek was 
within the range of naturally occurring T cells (1-50µM), we predicted that M2 specific T 
cells would develop in a B6.K mouse, in contrast to the highest affinity M15 TCR which 
would be negatively selected. Generation of the M2 TCR transgenic mouse allows 
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studies of specificity to be extended to a naturally developed T cell. The mouse also 
provides a way to study the selection of CD4 T cells expressing the M2 TCR. By 
comparing n3.L2 and M2 T cells, we can now determine how kon alters development and 
activation of T cells in vitro and in vivo.  
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CHAPTER 2 
 
CD4 T cell response to altered peptide ligand recognition 
correlates with kinetics of TCR:pMHC association 
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Introduction 
 
T cells are the main effectors of the adaptive immune system. Through recombination of 
V-(D)-J segments up to 109 T cells with different specificities can be produced in the 
thymus. The repertoire of T cells recognizes a wide variety of foreign peptides, though all 
T cells retain recognition of MHC (141, 142). Upon binding a cognate pMHC complex, a 
T cell will undergo a process of activation, starting with phosphorylation of molecules 
associated with the TCR and resulting in cytokine production, proliferation, and initiation 
of T cell help to other cells or cytolysis of infected target cells. TCR recognition of 
pMHC presented on APCs is a complex process, involving conformational changes to 
ensure optimal contact between the TCR and pMHC (14-17) and recruitment of 
costimulatory molecules to ensure full T cell activation (105-107, 143). There is a high 
degree of specificity and sensitivity for TCR binding pMHC, even with micromolar 
affinity. The TCR has inherent specificity for an agonist peptide but retains flexibility 
allowing sufficient interaction with slight variants of the agonist (20). This flexibility is 
critical during T cell development in the thymus and ensures recognition of mutated 
foreign antigens present during an infection. While flexible recognition of pMHC is an 
advantage in mounting an immune response against infection or tumor escape variants, 
highly promiscuous T cells can inappropriately recognize self-peptides and cause 
autoimmune disease (10, 21). Therefore, it remains important to understand the process 
by which a T cell discriminates between peptides to generate a productive, and 
appropriate, immune response.  
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TCR specificity for pMHC is encoded in the set of 6 complement determining 
regions. These CDR loops contact the pMHC interface generating the direct interactions 
between residues on the TCR and peptide side chains and residues on the MHC helices 
(144). It was discovered that subtle changes in the peptide do not abolish T cell activation 
(62). Instead the TCR is flexible enough to recognize these altered peptide ligands 
(APLs), though the strength of APL recognition regulates the level of T cell response. 
The energetics of bonds between the pMHC and the TCR CDR loops set a threshold for 
T cell activation (19). Therefore, APLs that still make sufficient contact with the TCR 
can overcome the activation barrier generating varying levels of T cell activation. It 
should be noted that not all amino acid changes result in APLs that are able to activate a 
T cell as some APLs, named null peptides, do not elicit a T cell response.  
APLs function in a distinct manner from wildtype ligands and have been shown to 
produce a variety of T cell activation phenotypes. APLs have induced IL-4 production 
without proliferation, altered the cytokine profile of T cells, functioned as antagonists to 
agonist activation, and induced anergy. APLs have been shown to induce a different 
pattern of signals downstream of the TCR as a consequence of partial T cell activation 
(42, 145). This state of partial activation may not be merely a reduced level of signaling 
or lack of costimulation but an entirely different activation state. As a consequence of 
partial activation, T cells stimulated by an APL can undergo anergy, a state of reduced or 
no proliferation and cytokine production (8, 65). Unlike anergy induction upon exposure 
to agonists, such as in a chronic infection, anergy from exposure to APLs cannot be 
overcome by costimulatory signals, further proof of a different rather than reduced 
signaling profile.  
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During thymic selection, T cells encounter a large number of peptide ligands that 
may be structurally different from specific antigens encountered in the periphery. To 
undergo full development, the T cell must recognize suboptimal ligands whereas stronger 
signals result in death by negative selection (9, 68, 69). By retaining TCR flexibility, a 
few peptides in the thymus can generate the diverse repertoire of T cells required to 
recognize a vast array of foreign antigens (71). APLs have been used to induce positive 
selection of transgenic T cells in vitro and in vivo (68, 73, 77, 78). The weakly 
stimulatory peptides used suggest APLs that can select peptides are of extremely low 
affinity. T cells selected in this method are still able to respond to agonists in the 
periphery. APLs have therefore been used as a method of “vaccination” against viruses, 
tumors, and autoimmunity by fine-tuning the specificity and affinity of T cells that 
develop (146-148).  
 Attempts have been made to understand the structural regulation of activation by 
APLs. It is now accepted that the state of T cell activation by an APL depends to some 
degree on the affinity of the TCR for the APL/MHC complex (1-4). Full activation of a T 
cell requires sufficient contact time between the TCR and pMHC (47, 48). Partial 
activation of T cells by APLs can be the result of fast dissociation rates or insufficient 
dwell time, which includes rebinding events, for productive signaling through the TCR 
(42). APLs that induce positive selection are of very weak affinity as they are unable to 
induce IL-2 production or proliferation in peripheral T cells (9, 78). Therefore, the 
spectrum of APL functions is due to the affinity of the TCR for the APL/MHC.  
  High affinity TCRs may have increased flexibility in recognizing peptides. 
Previous studies using a TCR mutant of the n3.L2 receptor showed that a high affinity 
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TCR is able to respond to a large number of APLs but retains specificity for cognate 
antigen (137). This dichotomy suggests further regulation of activation rather than just 
overall affinity of the complex. To measure how subtle changes in the TCR can alter 
recognition of APLs, we used n3.L2 and a mutant variant, M2, to examine the kinetic 
differences leading to T cell activation. Hybridomas expressing the M2 TCR responded 
to a larger number of Hb(64-76) APLs and produced more IL-2 upon stimulation by 
agonists than n3.L2 hybridomas. The M2 response was not due to increased affinity for 
all APLs. Instead, peptide specificity was maintained.  For instance, G69 was a stronger 
agonist for n3.L2. A69 was able to stimulate more CD69 upregulation on n3.L2 
thymocytes than M2 thymocytes. The structural differences between n3.L2 and M2 alter 
the generation of favorable bonds with the peptide, confirming specificity in recognition 
of APLs. While higher affinity TCR:APL/MHC complexes led to increased IL-2 
production, the KD did not accurately predict the level of activation. Instead, maximal  
IL-2 strongly correlated with koff, similar to what has previously been reported (43, 48).  
 
Materials and Methods 
 
Generation of n3.L2 and M2 hybridomas 
n3.L2 and M2 TCRα and β chains were cloned into a p2A retroviral vector with an 
IRES-GFP tag (pMIIG) developed by the Vignali lab (149), which places the α and β 
chains as a single polypeptide linked by the p2A peptide.  No stability mutations used in 
the yeast display were added into the sequence. The p2A peptide is cleaved 
posttranslationally, ensuring equal expression of the α and β chains and resulting in 
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efficient expression of transduced αβ TCRs. Viral particles were packaged in the PlatE 
cell line spinfected with 30µg retrovirus. Purified retrovirus containing supernatants from 
PlatE cells were used to infect the 58 α-β- CD4+ hybridoma cell line. M2 and n3.L2 
expressing hybridomas were generated simultaneously, sorted for comparable high GFP 
expression and equal expression of the n3.L2 and M2 TCRs. Cells were sorted a second 
time to generate a population with stable TCR expression. Equivalent expression levels 
of CD3, CD4, and TCR between n3.L2 and M2 were confirmed by flow cytometry. 
Surface TCR levels were assessed with CAb, Vβ8.3, and H57. Hybridomas were cultured 
in RPMI + 10% FCS + 1% β-2-mercaptoethanol + 1% Glutamax + 0.5% gentamycin.  
 
T cell hybridoma IL-2 production assay 
To assess T cell hybridoma responses, 5x105 hybridomas were cultured overnight at 37°C 
5% CO2 in wells of a 96-well plate with 2x104 CH27 B cell APCs and varying 
concentrations of the Hb(64-76) peptide from 0.0001-100µM. Peptides were synthesized 
in our laboratory and purified by HPLC prior to use. 18-20 hours after culture, 
supernatants were assayed using an IL-2 ELISA. Briefly, IL-2 was captured using an 
anti-IL-2 antibody (BioXCell) and detected with a second, biotinylated anti-IL-2 
antibody (BioLegend). Biotin-labeled IL-2 was detected by a streptavidin conjugated 
horseradish peroxidase antibody (Southern Biotech) followed by TMB substrate for 
accurate detection of 5-500 pg/mL of IL-2 (1-step Ultra TMB ELISA, Thermo 
Scientific). After stopping the reaction with 2M sulfuric acid, absorbance was read at 
450nm. Absorbance levels were converted into amount of IL-2 based on a regression 
analysis of IL-2 standards using GraphPad Prism (GraphPad Software). For the APL 
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studies, the amount of peptide required for 50% maximal IL-2 production (EC50) was 
calculated to determine relative levels of activation. For other experiments, the maximal 
IL-2 production and minimum stimulatory dose were compared.  
 
Surface Plasmon Resonance 
We used established lab protocols to measure binding affinities for n3.L2 and M2 single 
chain TCR (scTCR) to Hb(64-76)/I-Ek (137). Hb(64-76)-loaded I-Ek Ig dimers were 
directly coupled to a CM5 sensor chip by amine coupling. I-Ek dimers were produced in 
Drosophila S2 cells, as previously described (74, 150). Previously, refolded Hb(64-76)/I-
Ek was generated from E. coli inclusion bodies for use in SPR studies. Both ligands were 
tested in this system and the affinity measurements were the same using either the 
refolded monomer or Ig dimer and maintained a 1:1 TCR:MHC binding ratio ((140), data 
not shown). Data presented are based on measurements obtained using only peptide 
loaded I-Ek dimers. Refolded, soluble single chain n3.L2 or M2 TCR (Vα-linker-Vβ) 
(149) was purified by FPLC, concentrated in PBS, and injected over the bound I-Ek at a 
rate of 30µL/min. scTCR was injected in duplicate at increasing concentrations from 0-
100µM at 25°C. MCC loaded I-Ek was used as a negative control for binding. MCC 
sensograms were subtracted from experimental sensograms to eliminate nonspecific 
binding artifacts. Measurements were performed using a Biacore 2000. BiaEval version 
4.1 software (Biacore AB) was used to generate 1:1 Langmuir best fit approximation of 
sensograms to determine KD, koff and kon. The Langmuir model was adjusted until a Chi2 
value below 50 was obtained, indicating the best approximation of data. Kinetic 
measurements are compiled from 5 independent experiments using separate CM5 chips. 
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KD and koff values were confirmed by Scatchard analysis using GraphPad Prism 
(GraphPad Software). Statistical significance was measured by Student’s t test for 
differences between n3.L2 and M2 parameters.  
 
CD69 upregulation 
Pre-selection double positive (DP) thymocytes were isolated from thymi of TCR 
transgenic mice aged 4-6 weeks by depletion of DN and already selected cells with anti-
CD25-biotin (Biolegend, clone PC61), anti-CD44-biotin (Biolegend, clone IM7) and 
anti-CD53 (Biolegend, clone OX-79) antibodies. For anti-CD53, primary antibody 
labeling with unlabeled anti-CD53 was followed by addition of goat anti-rat IgM-biotin 
(Jackson Immuno Research) antibody. After incubation with the biotinylated antibody 
cocktail, Miltenyi anti-biotin microbeads were added and DP cells were isolated by 
negative selection on a Miltenyi AutoMACS. 1x105 isolated cells were cultured with 
either 5x105 Hb(64-76)-pulsed irradiated B6.K splenocytes or wells precoated for 2 days 
with 5µg/mL anti-CD28 (Biolegend, LEAF purified, clone 37.51) and increasing 
amounts of anti-CD3 (Biolegend, LEAF purified, clone 2C11) antibodies. After 18 hours 
of incubation at 37°C 5% CO2, cultures were measured for CD69 upregulation by flow 
cytometry. Cultures were gated on live lymphocytes, followed by gating on CD4+ CD8+ 
DP thymocytes, and assessed for percent CD69+. 
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Results 
 
Generation of an n3.L2 mutant with only an increased kon 
The n3.L2 TCR is specific for the Hbd(64-76) peptide presented on the I-Ek MHC class II 
molecule (62). Previously, the n3.L2 receptor was mutagenized using a yeast display 
system (139). Mutants were isolated by increased surface levels on yeast, indicating 
enhanced TCR stability. One mutant, M2, contained two point mutations in the CDR1α 
chain (K25E and T28S) in addition to mutations leading to stable expression of the TCR. 
Although it had not been selected for higher affinity binding to Hb(64-76)/I-Ek, M2 was 
shown to have several fold improved affinity over the n3.L2 TCR (137). Soluble single 
chain TCR molecules (Vα-linker-Vβ; scTCR) were generated for the n3.L2 and M2 T 
cell receptors (149), containing several additional stabilizing mutations in framework 
regions (151). These scTCR stabilizing mutations were needed to produce the soluble 
scTCR, but not for expression of the mutants in T cell (140). The scTCRs were used 
previously to measure binding affinity of the series of mutants to Hb(64-76)/I-Ek by 
surface plasmon resonance. To confirm and extend these studies, we performed similar 
surface plasmon resonance studies. n3.L2 had an affinity of 16.6µM for Hb(64-76)/I-Ek  
(Table 2.1). M2 had a 3.7 fold higher affinity for Hb(64-76)/I-Ek (4.3µM) due to an 
equivalent change in kon, without a significant change in koff (Figure 2.1A, Table 2.1). 
Sensograms of increasing concentrations of scTCR up to 100µM were modeled for a 1:1 
binding ratio to determine kinetic measurements of n3.L2 and M2 scTCR binding to 
Hb(64-76)/I-Ek dimers (Figure 2.1B). The KD values were confirmed by Scatchard 
analysis (Figure 2.1C). These kinetic values were consistent with what was originally 
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reported for n3.L2 and M2 (137). Therefore, the M2 TCR has an increased affinity for 
Hb(64-76)/I-Ek due solely to a faster kon. 
 
n3.L2 and M2 hybridomas had the same sensitivity and maximal IL-2 production in 
response to Hb(64-76)/I-Ek 
The M2 TCR had not been previously tested functionally. Because the M2 mutations 
altered the affinity of the TCR for pMHC, we predicted M2 T cells would differ in their 
response (sensitivity or specificity) to the Hb(64-76) peptide in comparison with n3.L2 T 
cells. To measure the sensitivity of n3.L2 and M2 TCRs to Hb(64-76)/I-Ek, we generated 
a set of T cell hybridomas using a retroviral system designed by the Vignalli lab (149). 
Sorted n3.L2 and M2 hybridomas expressed equivalent levels of the n3.L2 or M2 TCR 
and CD4 (Figure 2.2). Hybridomas were stimulated by CH27 cells pulsed with varying 
doses of purified Hb(64-76) peptide. n3.L2 and M2 response to agonist stimulation was 
measured by IL-2 production. The response curves for the n3.L2 and M2 hybridomas 
were the same, with the same maximal response and sensitivity to the Hb(64-76) peptide 
(Figure 2.3). A similar result was obtained for a related, higher affinity TCR, M15 (137). 
Therefore, the M2 TCR is fully functional and equivalent to the n3.L2 TCR in its ability 
to recognize and be stimulated by Hb(64-76)/I-Ek independent of effects from 
development. 
 
n3.L2 and M2 T cells differ in response to Hb(64-76) APLs 
Since the affinity difference did not alter recognition of the Hb(64-76) peptide, we 
examined TCR specificity for peptide by testing the ability of Hb APLs to stimulate the 
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n3.L2 and M2 hybridomas. A panel of 76 peptides was generated by singly substituting 
each amino acid at the 4 TCR contact residues and tested for the ability to stimulate IL-2 
production. This panel was previously used to characterize the reactivity of the M4 and 
M15 mutants of the n3.L2 TCR. However, both of those mutants contained CDR3 
mutations, which most likely contribute to the broad reactivity measured (137). APLs 
were ranked for their ability to stimulate IL-2 production relative to the WT Hb(64-76) 
peptide according to EC50 values. A 4-log range of APL reactivity was measured, from 
null peptides to weak and strong agonists. Of the 76 APLs, 13 APLs stimulated IL-2 
production by the n3.L2 hybridomas (Figure 2.4), whereas, 25 of the 76 peptides were 
agonists for M2 hybridomas. M2 recognized changes at each of the 4 TCR contact 
residues.  M2’s broader response to APLs suggests the structural changes that led to the 
faster kon and increased affinity of M2 for wildtype Hb(64-76) peptide also raised the 
affinity of a number of APLs over the threshold for agonist stimulation. Thus, the 
increase in kon of the M2 T cells has a functional affect in that it broadens the number of 
APLs which are stimulatory. 
Additionally, M2 hybridomas were more sensitive to some APLs that were 
agonistic for n3.L2 and M2 hybridomas, with a lower EC50 value for IL-2 production 
(Figure 2.5). For example, the M69 APL stimulated both n3.L2 and M2 hybridomas 
(Figure 2.5A). The EC50 for M2 was 5µM with a maximal IL-2 production at 350 pg/mL. 
M69 was able to stimulate n3.L2 hybridomas at concentrations as low as 3.1µM but did 
not produce maximal IL-2 at 100µM, the highest concentration testable. A similar 
difference was seen with the D70 APL. M2 hybridomas produced more IL-2 in response 
to D70 but the sensitivity of the two hybridomas was similar (Figure 2.5B). T72 (Figure 
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2.5C) and V75 (Figure 2.5D) were null peptides for the n3.L2 hybridomas. Interestingly, 
both stimulated IL-2 production by M2 hybridomas. T72 went from a null peptide for 
n3.L2 to a strong agonist for M2, only 10-fold less stimulatory than wildtype Hb(64-76), 
while V75 was only a weak agonist. While M2 was a stronger responder in most cases, 
no pattern emerged in terms of structure to predict which APLs would be activating. It 
seemed likely that changes in the affinity were regulating the APL response.  
 
koff of TCR:APL/I-Ek interaction correlates with maximal IL-2 production 
Since IL-2 production, including maximal IL-2 production, is dependent upon the 
kinetics of TCR contacting the specific pMHC complex, we used surface plasmon 
resonance to measure the binding affinity of n3.L2 and M2 scTCRs to I-Ek dimers loaded 
with specific APLs. Purified single chain n3.L2 and M2 TCRs were injected over flow 
cells with amine coupled APL/I-Ek Ig dimers. As predicted, the higher the affinity, the 
stronger the IL-2 production. However, the overall affinity of TCR:pMHC did not 
completely reflect the level of IL-2 production by the n3.L2 and M2 hybridomas. N3.L2 
had an affinity of 16µM for wildtype Hb(64-76)/I-Ek and M2 had an affinity of 4.4µM 
though IL-2 production was nearly identical.  
The lowest affinity measured was for n3.L2 interacting with H70/I-Ek (Figure 2.6, 
Figure 2.7, Table 2.2). H70 failed to induce IL-2 production by the n3.L2 hybridomas. 
Accordingly, n3.L2 bound H70/I-Ek with an affinity of 158µM. M2 hybridomas 
produced IL-2 at an EC50 lower than for wildtype Hb(64-76) the result of a 37µM 
affinity. Interestingly, the difference in affinity and activity was the result of changes in 
kon and, more dramatically, in koff. M2 had a faster kon in binding H70, which could 
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account for the increased sensitivity, overcoming a fast koff, as has been reported for other 
systems(47, 48).  
V69 was an agonist for both n3.L2 and M2 hybridomas (Figure 2.4). Agonistic 
activity was the same as wildtype Hb(64-76) for M2 but was 10-fold weaker for 
stimulating n3.L2. Correspondingly, M2 bound V69 with an affinity of 17µM similar to 
that measured for the wildtype peptide and stronger than the 54µM for n3.L2:V69/I-Ek 
(Figure 2.6, Table 2.2). The affinity change in this case was driven by changes solely in 
the koff. The affinity measured for n3.L2:V69/I-Ek is weaker than expected given the IL-2 
response.  
The affinity of n3.L2 and M2 for E70 did not correlate with affinity (Figure 2.6, 
Figure 2.8, Table 2.2). E70 stimulated weak IL-2 production from n3.L2 hybridomas, 
requiring 100-fold more peptide than wildtype Hb(64-76). M2 hybridomas were 10-fold 
more sensitive to E70 than n3.L2 hybridomas. However, the affinity of M2 for E70/I-Ek 
was 2 times weaker than n3.L2 binding E70. Interestingly, M2 had a slower koff and 
significantly higher Emax for IL-2 production. E70 may lend credence to the dependence 
of Emax on koff (43). Additionally, a correlation was only measured between the Emax and 
koff using our combined kinetic and APL response data, confirming the relationship. 
Interestingly, the G69 APL was a stronger agonist for n3.L2 than for M2. M2 had 
an EC50 value 10-fold lower than n3.L2 for IL-2 production in response to G69. N3.L2 
had a stronger affinity than M2 for G69 (Figure 2.6, Figure 2.9, Table 2.2). The affinity 
difference was driven by kon, since the koff remained the same for the n3.L2 and M2 
complexes with G69/I-Ek. By having a slower kon for TCR:pMHC, the M2 hybridomas 
produced significantly less IL-2 than the n3.L2 hybridomas, even with 100µM peptide. 
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This result suggests that in addition to koff, kon may regulate Emax for IL-2 production. 
Overall, the APL studies highlight the importance of kinetics in determining the 
activation outcome of TCR:pMHC. As has been seen with other systems, the Hb APLs 
are able to induce IL-2 production to varying levels given a TCR affinity above the 
threshold for recognizing presented APLs. Fine tuning by both kon and koff of complex 
formation set the sensitivity of TCRs to stimulation and maximal IL-2 production levels.  
 
A larger percentage of M2 DP thymocytes upregulate CD69 in response to wildtype 
Hb(64-76) and APLs that failed to stimulate IL-2 production by peripheral T cells 
A majority (51/76) of the APLs were null peptides for both n3.L2 and M2 hybridomas. 
However, the peptides involved in positive selection of thymocytes are of low enough 
affinity that they cannot stimulate IL-2 production by peripheral T cells (9, 78). As 
thymocytes are more sensitive to stimulatory signals, we tested the ability of APLs to 
induce CD69 upregulation on DP thymocytes. CD69 is upregulated on DP thymocytes 
that have received a positive selection signal, though this is quickly downregulated in the 
thymus (152). Isolated DP thymocytes from n3.L2 and M2 TCR transgenic mice were 
cultured with irradiated B6.K splenocytes pulsed with wildtype Hb(64-76) or APLs. (The 
M2 TCR transgenic mouse is described in detail in Chapter 3. This was not included here 
to maintain the flow of each storyline.) After 18 hours, cultures were analyzed by flow 
cytometry for CD69 upregulation. n3.L2 and M2 DP thymocytes had the same ability to 
upregulate CD69 in response to anti-CD3 + anti-CD28 stimulation, indicating no inherent 
cellular difference in signaling downstream of the TCR (Figure 2.10A).  
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We next tested antigen specific CD69 upregulation, which reflects recognition of 
endogenous pMHC during selection. A greater proportion of M2 DP thymocytes were 
CD69 positive 18 hours after stimulation with Hb(64-76) peptide in comparison to n3.L2 
DP thymocytes (Figure 2.10B). Therefore the increased sensitivity of thymocytes 
uncovered a difference in sensitivity to the Hb(64-76) peptide that may be detuned as a 
consequence of the decreased sensitivity of peripheral thymocytes. These results suggest 
the increased affinity of the M2 TCR for Hb(64-76)-I-Ek resulted in stronger signaling 
through the TCR.  
A larger percentage of M2 DP thymocytes upregulated CD69 in comparison to 
n3.L2 DP thymocytes in response to the majority of the APLs tested (Figure 2.11), 
including those deemed null peptides from peripheral T cell stimulation (Figure 2.4). 
Therefore the affinity of M2 for APLs that failed to stimulate peripheral cells may be 
stronger than n3.L2 in the thymus, potentially as a result of increased affinity for MHCII. 
Like in the periphery, the M2 mutations set the binding energetics close to the threshold 
for selection permitting recognition of a broader range of APLs. Interestingly, the A69 
APL induced greater CD69 upregulation on the n3.L2 thymocytes. Like G69 in the 
periphery, the n3.L2 CDR1α residues must permit favorable interactions with the A69 
residue which are altered with the M2 CDR1α. The permissible amino acid changes are 
dictated by the structure of the TCR, maintaining TCR specificity even with enhanced 
affinity.  
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Discussion 
 
The M2 TCR has a stronger affinity for Hb(64-76)/IEk than the wildtype n3.L2. 
The same changes in the CDR1α loop that lead to an increased kon for the TCR:pMHC 
interaction set the binding energetics of M2 with peptide loaded I-Ek near the threshold 
for T cell activation. As such, M2 expressing hybridomas are more sensitive to and 
produce higher levels of IL-2 in response to Hb(64-76) APLs. A larger number of the 
APLs were able to activate M2 hybridomas than n3.L2 hybridomas. Interestingly, while 
the overall sensitivity did not correlate with affinity or kinetics, the maximal IL-2 level 
(Emax) correlated with the koff of the TCR:APL/I-Ek complex. This confirms results 
previously published by Dushek et al. (43). Thymocytes isolated from M2 and n3.L2 
TCR transgenic mice were more sensitive to APLs, upregulating CD69 in response to 
APLs that were null for stimulating hybridomas. Again, M2 DP thymocytes responded to 
a larger number of APLs, suggesting the same principles at work for peripheral T cells 
also regulate thymocyte responses. Interestingly, in both the hybridoma and DP 
thymocyte responses, APLs were identified that better stimulated cells expressing the 
n3.L2 receptor. This suggests that while the M2 TCR may have a stronger affinity for 
pMHC complexes in general, the orientation of residues in the CDR1α loop restricts 
productive association with the P2 site of the peptide. Therefore, the M2 TCR still retains 
specificity instead of responding more strongly to all peptide mimics.  
 While the overall affinity and kon did not seem to correlate with the presented 
kinetic and activation measurements, the system studied here may be too simplified. In 
addition to TCR affinity, the CD4 coreceptor and costimulatory receptors on the T cell 
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surface may fine-tune T cell activation (105-107). We did not include these molecules in 
our analysis of activation or kinetics. By including CD4 in kinetic measurements a 
stronger correlation with KD may be observed, though some high affinity TCRs are CD4 
independent (81). The values presented in this analysis are significantly weaker than 
previously published data sets (12, 47, 48). Confinement time is not predicted to be a 
restriction due to the small magnitude of kinetic values for our system, though it may 
exacerbate the difference between M2 and n3.L2 interactions with Hb(64-76)/I-Ek 
(personal communication with C. Govern). This factor was found to reliably correlate to 
1G4 binding with pMHC mutants by Aleksic et al. (48). They hypothesized that while 
some interactions are dominated by koff, as previously reported, changes in koff can mask 
the contribution of kon. Instead, TCR and pMHC complexes with increased kon can be 
retained in proximity far longer than predicted by diffusion and koff. Complete T cell 
activation can then occur by multiple rebinding events with a pMHC molecule. To 
completely examine the role of kon in regulating TCR response, data sets need to be 
expanded. In our examination of the kinetics of our two TCRs binding APLs only one 
additional interaction was influenced by changes in kon rather than koff. Interestingly, this 
interaction seemed to depend more on the structure of the TCR, as G69 seems to more 
productively associate with n3.L2 rather than M2. Therefore, kon may indicate 
conformational shifts are required for full T cell activation, as suggested by the induced-
fit hypothesis (1, 60).  
 The kinetic measurements discussed in our system were performed using 3D 
binding on restricted ligand surfaces. Huang et al. (153) recently suggested that 2D 
kinetics more accurately predict in vivo affinity than 3D, such as SPR values. The 2D kon 
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and koff values are drastically different than 3D and also are more sensitive to kinetic 
differences for peptides. 2D may more accurately predict the stimulatory ability of 
peptides (25). The 2D system takes into account adhesion to multiple ligands clustered in 
a cell membrane. Using adhesion and thermal fluctuation assays, Huang et al. suggest 
that CD8 T cells rapidly contact multiple pMHCs, the rate of which is mainly driven by 
kon compensating for a fast koff. This study suggests that the differences observed in our 
system might be magnified in vivo and potentially gives us another way to model our 
kinetic interactions. In another system, it was identified that kon variation is increased in 
vivo (41), lending further credit to the potential role of kon.  
 The response of a T cell to APLs mimics the ability to recognize variations in 
endogenous peptides during thymic selection. M2 thymocytes were more sensitive to 
APLs, upregulating CD69 on a larger percentage of cells, even APLs that were unable to 
induce IL-2 production by hybridomas. The increased recognition of APLs may reflect an 
ability to recognize a larger pool of self-peptides in the thymus, suggesting increased 
levels of selection of M2 thymocytes. However, positive selection requires low affinity 
interactions (9, 68, 73, 75-77). By increasing the affinity of the M2 TCR for I-Ek, 
peptides that select the n3.L2 TCR may bind M2 with too high affinity leading to 
negative selection. When the n3.L2 mouse was crossed to express the A72 APL 
endogenously, a small population of n3.L2 T cells were deleted by negative selection 
(154). APLs of the A10 T cell depleted DP thymocytes at doses that were antagonistic to 
peripheral T cells (155). These studies suggest that a TCR with slightly higher affinity for 
APLs may in fact develop as a hyporesponsive T cell, unable to mount an effective 
immune response. 
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Selection in the thymus then sets the responsiveness of T cells in the periphery by 
promoting the development of mid affinity TCRs. Signaling downstream of the TCR 
depends on the strength of the interaction with antigen in the periphery. A longer half-life 
and dwell time for a TCR:pMHC complex enhances phosphorylation of CD3ζ and Zap-
70 (42), increases Ca2+ influx, and supports T cell proliferation. The affinity of 
TCR:pMHC association may regulate the timing of downstream signaling cascades by 
altering strength of TCR proximal signaling (51). However, a stronger affinity does not 
always correlate with better effector function. Many efforts have attempted to use APLs 
to boost an immune response to clear chronic viral infections or tumors (147). Exposure 
of a T cell to a high potency agonist in vivo results in an attenuated response, presumably 
as the result of some negative feedback though not necessarily through CTLA-4 (134). 
This hyporesponsive state may be due to changes in the TCR binding presented 
antagonist peptides (8, 35). A T cell may need to retain antigen specificity to effectively 
enhance an immune response or target cells for lysis (156). Detuning or increasing the 
affinity by use of the TCR coreceptor may be an effective way to maintain T cell 
specificity and reactivity. In two separate systems, mid/low-affinity CD8 T cells lysed 
tumor cells, potentially with enhancement by the CD8 coreceptor, whereas high-avidity 
CD8 T cells failed to clear tumors and did not respond to agonist ex vivo (156, 157).  
T cell affinity must be regulated, to be not too strong and not too weak, to 
effectively activate upon recognition of specific antigens and mount an immune response. 
Evidence has determined that the 3D affinity of a TCR for pMHC does not entirely 
predict its response. While koff may reflect the maximal response, other parameters 
moderate T cell activation in vivo. Perhaps future studies utilizing systems like M2 versus 
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n3.L2 in vivo will provide more concrete ways to predict the potency of antigen in 
stimulating a T cell and if that is due to a TCR:pMHC interaction that is just right. 
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Figure 2.1 Kinetics of n3.L2 and M2 scTCRs binding Hb(64-76)/I-Ek Ig dimers 
A. Kinetics of n3.L2 and M2 were measured by surface plasmon resonance using scTCRs 
binding to Hb(64-76)/I-Ek dimers. Values in arrows indicate fold change above n3.L2 for 
kon measurements. Measurements are averages of 5 independent experiments on separate 
CM5 chips. Statistical differences were determined using Student’s t test. B. scTCR was 
injected over flow cells coupled with Hb(64-76)/I-Ek dimer. Representative sensograms 
are shown for scTCR injections at the indicated concentrations. Kinetic constants were 
calculated by fitting sensograms to a 1:1 Langmuir binding model. C. Equilibrium 
responses at each scTCR concentration were used to generate Scatchard plots of n3.L2 
and M2 to confirm values predicted from 1:1 modeling. The response was highly linear, 
with r2 values of 0.8, indicating a 1:1 binding ratio between the TCR and each arm of the 
I-Ek Ig dimer.  
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Figure 2.2 Characterization of n3.L2 and M2 hybridomas 
Hybridomas were sorted for the top 10% GFP+ to generate a population of retrovirally 
infected 58α-β- cells expressing either the n3.L2 or M2 TCR. Surface levels of CD4 and 
TCR were measured by flow cytometry. n3.L2 (black) and M2 (filled) histogram 
overlays for CD4, Vβ8.3, and the TCR clonotypic antibody, CAb.  
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Figure 2.3 Response of n3.L2 and M2 hybridomas to WT Hb(64-76) 
IL-2 production by n3.L2 (blue square) and M2 (green triangle) hybridomas in response 
to wild-type Hb(64-76). Hybridomas were cultured in triplicate for 18-20 hours with 
peptide loaded CH27 APCs. Mean + SEM is presented for triplicates at each 
concentration in the dose curve, which is representative of 6 independent experiments.  
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Figure 2.4 Response of M2 and n3.L2 hybridomas to Hb(64-76) APLs 
Response of n3.L2 and M2 hybridomas to Hb(64-76) APLs. All 20 amino acids were 
substituted individually into each of the 4 TCR contact positions in the Hb(64-76) peptide 
(P2, P3, P5 and P8). Wildtype Hb(64-76) residues are noted under the label for each 
position. APLs that induced IL-2 production are shaded according to their stimulatory 
ability relative to the wildtype Hb(64-76) peptide. 13/76 APLs were agonists for n.3L2. 
25/76 APLs were agonists for M2 hybridomas. Each APL was tested in triplicate up to 
100µM in at least 3 independent experiments.  
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Figure 2.5 IL-2 response by n3.L2 and M2 hybridomas to APLs 
A-D. Stimulation of IL-2 production by n3.L2 (blue square) and M2 (green triangle) 
hybridomas with example APLs from each TCR binding position. Mean + SEM is 
presented for the full dose curve which is representative of 4 independent experiments.  
A. Stimulation with M69. B. Stimulation with D70. C. Stimulation with T72. D. 
Stimulation with V75 and wildtype Hb(64-76) for comparison.  
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Figure 2.6 Relative kinetic measurements binding to APLs 
Visual representation of kinetic measurements determined by surface plasmon resonance 
for n3.L2 and M2 scTCRs binding to APL loaded I-Ek dimers. Presented are mean + SD 
for 1-5 separate experiments on new CM5 chips. Values above the x-axis are measured 
kon, below are koff.  
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Figure 2.7 Kinetics and response to APL H70 
Representative IL-2 response of n3.L2 and M2 hybridomas to doses of H70 APL up to 
314µM. Each dose was measured in triplicate in at least 3 independent experiments. 
Kinetics of n3.L2 and M2 scTCRs binding to H70/I-Ek dimers by surface plasmon 
resonance. Presented are mean + SD for 2 separate experiments on new CM5 chips.  
  
57 
 
                      
58 
 
 
Figure 2.8 Kinetics and response to APL E70 
Representative IL-2 response of n3.L2 and M2 hybridomas to doses of E70 APL up to 
100µM. Each dose was measured in triplicate in at least 3 independent experiments. 
Kinetics of n3.L2 and M2 scTCRs binding to E70/I-Ek dimers by surface plasmon 
resonance. Presented are mean values for 1 experiment performed in duplicate.   
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Figure 2.9 Kinetics and response to APL G69 
Representative IL-2 response of n3.L2 and M2 hybridomas to doses of  G69 APL up to 
314µM. Each dose was measured in triplicate in at least 3 independent experiments. 
Kinetics of n3.L2 and M2 scTCRs binding to G69/I-Ek dimers by surface plasmon 
resonance. Presented are mean + SD for 2 separate experiments on new CM5 chips.  
  
61 
 
                             
62 
Figure 2.10 CD69 upregulation in response to Hb(64-76) and anti-CD3 + anti-CD28 
DP thymocytes were isolated from n3.L2 (blue squares) or M2 (green triangles) thymi 
and cultured for 18 hours with Hb(64-76) pulsed APCs (A) or plate bound anti-CD3 + 
anti-CD28 (B). CD69 upregulation was measured by flow cytometry. Populations were 
gated on DP thymocytes and percent CD69 was recorded. Presented are mean and SEM 
of 4 independent experiments for anti-CD3 + anti-CD28 (A) and 8 independent 
experiments for Hb(64-76) (B). p values determined by Χ2 to test higher CD69 levels in 
the M2 population.  
  
63 
 
                          
64 
Figure 2.11 CD69 upregulation by DP thymocytes in response to APLs 
DP thymocytes were isolated from n3.L2 (blue squares) or M2 (green triangles) thymi 
and cultured for 18 hours with APL pulsed APCs at multiple doses (left) or a single dose 
of 0.3µM (right) in duplicate. CD69 upregulation was measured by flow cytometry. 
Populations were gated on DP thymocytes and percent CD69+ was recorded.  Presented 
are mean and SEM for at least 2 independent experiments at each dose.  
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Table 2.1 Kinetics of n3.L2 and M2 scTCRs binding Hb(64-76)/I-Ek 
Kinetics of n3.L2 and M2 were measured by surface plasmon resonance using scTCRs 
binding to Hb(64-76)/I-Ek dimers. Measurements of n3.L2 and M2 kinetics are averages 
of 5 independent experiments on separate CM5 chips.  
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Table 2.2 Correlation between kinetics and response to APLs 
Kinetics of n3.L2 and M2 were measured by surface plasmon resonance using scTCRs 
binding to Hb(64-76) or APL loaded I-Ek dimers. Measurements of n3.L2 and M2 
kinetics are averages of 1-5 independent experiments on separate CM5 chips. Emax and 
EC50 values determined for IL-2 production by n3.L2 and M2 hybridomas stimulated 
with wildtype Hb or APL pulsed APCs. Correlation between kinetic measurements and 
IL-2 production was determined using a Pearson’s correlation.  
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CHAPTER 3 
 
kon of TCR:pMHC affinity drives changes  
in selection and activation of CD4 T cells 
  
71 
Introduction 
 
The TCR affinity for pMHC regulates outcomes of T cell selection in the thymus and 
activation of T cells in the periphery (1-4). Agonist peptides induce full T cell activation 
through strong interactions with the TCR (3, 5). Weaker TCR:pMHC interactions can 
result in partial T cell activation (6) or anergy (7, 8). Positive selecting, TCR:endogenous 
pMHC interactions are also of very low affinity (9). The affinity (KD) of the TCR:pMHC 
complex is determined by the dissociation rate (koff) and association rate (kon). Kinetic 
and thermodynamic parameters for the TCR:pMHC interaction have been correlated with 
T cell activation (12, 39, 41-45, 47, 48), however there is no consensus for one parameter 
being a predictor of a peptide’s ability to stimulate a TCR (46). A few studies have 
suggested a role for kon. Recently, it was shown that a stimulatory pMHC with a fast koff 
could compensate with a fast kon resulting in sufficient interaction between the TCR and 
pMHC for full activation (47, 48). These studies clearly revealed that changes in kon can 
affect the ability of a peptide to stimulate a T cell, but these conclusions were based on 
TCR:pMHC combinations in which there were changes in both kon and koff. Therefore, it 
remains important to understand the individual contribution kon makes in determining T 
cell selection and activation. 
The TCR:pMHC binding footprint is a specific but flexible structure (20). TCR 
specificity for pMHC is encoded in the variable CDR loops, which form the binding 
footprint for TCR to contact the pMHC complex (23, 24). TCR specificity for MHC is 
primarily through interactions with CDRs 1 and 2 (25, 26), though CDR3 can directly 
contact MHC (158). It is thought that the highly conserved CDRs 1 and 2 have “germline 
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encoded” interaction with an MHC. This is best defined for T cells using Vβ8.2 in which 
a set of conserved interactions exist between two tyrosines and a glutamic acid residue of 
the TCR CDR2β and the MHC class II α chain (26-28). Mutations in the CDR 1 and 2 
loops can result in generation of high affinity TCRs (29, 30), potentially as a consequence 
of an optimal binding conformation or enhanced TCR:pMHC stability (16, 20, 31, 32). In 
the general diagonal orientation of the TCR on pMHC, the CDR3 loops are positioned 
across from the peptide in the MHC binding groove providing direct interactions with 
specific amino acid side chains (17, 22, 35). The sum of binding energetics between the 
TCR and pMHC dictate the overall affinity of the complex and determine how a T cell 
will respond to a specific peptide presented on MHC in both the thymus and periphery 
(19).  
There is an affinity continuum of a TCR for endogenous pMHC that regulates 
selection of T cells in the thymus (67). T cells must have sufficient affinity for 
endogenous pMHC above the threshold for positive selection but below the threshold for 
negative selection (9, 68, 69). T cells on the low end of the affinity spectrum fail to 
recognize pMHC and die from neglect (70). The threshold for positive selection is set by 
partial or low level T cell activation. High affinity recognition of self pMHC can result in 
negative selection. High affinity TCR:pMHC interactions have a longer contact time 
leading to increased signaling through the TCR (78). Negative selection is a digital 
response due to the accumulation of specific signals downstream of the TCR (87), 
resulting in apoptosis of high affinity T cells to establish central tolerance (77, 78). While 
the majority of self-reactive T cells are deleted to generate central tolerance, it is thought 
that Tregs can develop from these self-reactive, high affinity TCRs (159). Treg 
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development is not merely a consequence of a high affinity TCR, however, as specific 
environmental cues and TCR sequences may also be required (160, 161). A complex set 
of distinct signals regulates positive and negative selection (76, 119), tuning T cell 
responsiveness in the periphery.  
Negative selection is an incomplete process, however, and some high affinity T 
cells escape to the periphery where they can cause autoimmune disease (122). While 
failure to eliminate these cells leaves a population of potentially self-reactive cells, a 
back-up system is in place to prevent autoimmunity (162). Potentially autoreactive T 
cells can be rendered unresponsive to antigenic stimulation (123) or deleted in the 
periphery to establish peripheral tolerance (78) against antigens that are in low 
concentrations or not available during thymic selection. Anergy, a state of 
hyporesponsiveness characterized by low IL-2 production and inhibited proliferation 
(123), has been induced in naive T cells through lack of costimulation (125), exposure to 
APLs (6, 8, 77), or low stimulation through the TCR as a result of either low affinity 
interactions (86, 128, 129) or unstable pMHC complexes (128). In vivo, a high affinity 
interaction can lead to an attenuated T cell response by altering intracellular signaling 
(134), or rapidly deleting the T cells (163). Activation following suboptimal stimulation, 
such as in the absence of costimulation or with high immunosuppressive signals, results 
in a phenotype akin to anergy (124). Anergized T cells downregulate TCR and 
costimulatory receptors to maintain the hyporeactive state (130). Low expression of a 
TCR in the thymus results in reduced positive selection in addition to anergy in the 
periphery (86). Because of the dual role of T cell affinity in selection and activation, the 
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propensity for T cells to undergo tolerance may be set in the thymus by the affinity of the 
expressed TCR for self pMHC.  
We have generated a novel system to examine how the kon of the TCR binding 
pMHC regulates T cell selection and activation. This system compares two TCRs 
recognizing the same cognate antigen, Hb(64-76)/I-Ek.  In the mouse, the Hb protein 
exists in two naturally occurring allelic variants, Hbd and Hbs, such that T cells can 
develop normally in Hbs strains and be reactive to cells from Hbd mice. The n3.L2 TCR 
was generated against the Hbd version of the (64-76) peptide (62). A yeast display system 
was utilized to generate higher affinity variants of the n3.L2 receptor (137, 138). The 
highest affinity variant, M15, has previously been studied. M15 recognized Hb(64-76) 
with the same sensitivity as the original n3.L2 TCR (137, 140). Because of its increased 
affinity, M15 had broader recognition of Hb APLs and had sufficient affinity to respond 
to weak n3.L2 ligands (138). While providing insight into the sensitivity of the TCR for 
low affinity pMHC, these studies were only conducted in vitro and failed to answer 
questions about how kinetics regulate the TCR in a naturally selected T cell. 
Additionally, the increased affinity of M15 is due to changes in both the kon and koff. 
Therefore, the question of the contribution of kon in selection and activation of T cells 
remains. 
A second variant, M2, has two amino acid changes in the CDR1α region resulting 
in a 3.7 fold higher affinity due specifically to a faster kon. We generated an M2 TCR 
transgenic mouse to test the effects of kon in vivo. While the measured affinity of M2 for 
Hb(64-76)/I-Ek is within the range of naturally occurring T cells (1-50µM), M2 T cells 
underwent negative selection as a result of the faster kon in the recognition of pMHC. M2 
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T cells that escaped negative selection to generate the peripheral T cell population were 
hyporesponsive to Hb stimulation. The faster kon for M2 binding pMHC may set the 
affinity of M2 for I-Ek near the threshold for activation, increasing TCR stimulation by 
pMHC during selection and activation. Therefore, the kon for TCR binding pMHC 
influences signaling through the TCR and thereby regulates T cell selection and 
activation outcomes.  
 
Materials and Methods 
 
Generation of the M2 TCR transgenic mouse line 
The M2 mouse was generated using the method described for the n3.L2 mouse (79). The 
n3.L2 V-Jα plasmid was mutated by PCR to express the two amino acid changes in the 
M2 CDR1α chain. The M2α chain was cloned into the TCR shuttle vector. TCRα and β 
minigene constructs were coinjected into C57/BL/6 pronuclei in the Washington 
University Department of Pathology and Immunology’s Transgenic Core Facility. 
Transgenic mice were identified by PCR amplification of the M2α and β transgenes from 
tail DNA. Expression of the M2α chain was confirmed by sequencing the founders’ 
genomic DNA. One founder expressed both the M2α and β transgenes and was bred to 
the B6.K strain to provide the selecting MHC. Peripheral CD4 T cells in the M2/B6.K 
mouse stained with the clonotypic antibody, CAb. M2 and n3L.2 mice were further 
crossed to a Rag-1-/- background producing n3.L2/B6.K/Rag1-/- and M2/B6.K/Rag1-/- 
mice. Mice were used at 4-8 weeks of age in these studies, unless otherwise noted.  All 
mice were bred and maintained in a pathogen-free barrier facility within Washington 
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University in St Louis following a protocol approved by and in accordance with 
guidelines from the Washington University Division of Comparative Medicine. 
 
Generation of n3.L2 and M2 hybridomas 
n3.L2 and M2 TCRα and β chains were cloned into a p2A retroviral vector with an 
IRES-GFP tag (pMIIG) developed by the Vignali lab (149), which places the α and β 
chains as a single polypeptide linked by the p2A peptide.  No stability mutations were 
added into the sequence. The 2A peptide (p2A) is cleaved posttranslationally, ensuring 
equal expression of the α and β chains and resulting in efficient expression of transduced 
αβ TCRs. Viral particles were packaged in the PlatE cell line spinfected with 30µg 
retrovirus. Purified retrovirus containing supernatants from PlatE cells were used to infect 
the 58 α-β- CD4+ hybridoma cell line. M2 and n3.L2 expressing hybridomas were 
generated simultaneously, sorted for comparable high GFP expression, and equal 
expression of the n3.L2 and M2 TCRs. Cells were sorted a second time to generate a 
population with stable TCR expression. Equivalent expression levels of CD3, CD4, and 
TCR between n3.L2 and M2 hybridomas were confirmed by flow cytometry. Surface 
TCR levels were assessed with CAb, Vβ8.3, and H57. Hybridomas were cultured in 
RPMI + 10% FCS + 1% β-2-mercaptoethanol + 1% Glutamax + 0.5% gentamycin.  
 
T cell IL-2 production and proliferation assays 
For isolated T cell stimulation, single cell suspensions were made from pooled 
lymph nodes and spleen from transgenic mice. CD4+ cells were isolated by negative 
selection using a Miltenyi CD4 II isolation kit (Miltenyi Biotec). Non-CD4+ cells were 
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depleted by binding to a Miltenyi AutoMACS column. Purity was tested by flow 
cytometry analysis for percent CD4+ CAb+. To account for minor variations in the purity 
between n3.L2 and M2 isolation, cell numbers were normalized to the percent CD4+ 
CAb+ cells to ensure the same number of specific CD4 cells were plated in each well of 
the IL-2 or proliferation assays. 1x105 specific CD4 cells were plated in I10+ (IMDM + 
10% FCS  + 1% L-glutamine + 1% non-essential amino acids + 1% β2-mercaptoethanol 
+ 0.5% gentamycin) with 5x105 irradiated B6.K splenocytes and varying concentrations 
of purified Hb(64-76) peptide from 0.0001-100µM. 18-20 hours after at 37°C 5% CO2, 
supernatants were assayed using an IL-2 ELISA. Briefly, IL-2 was captured using an 
anti-IL-2 antibody (BioLegend) and detected with a second, biotinylated anti-IL-2 
antibody (BioXCell). Biotin-labeled IL-2 was detected by a streptavidin conjugated 
horseradish peroxidase antibody (Southern Biotech) followed by TMB substrate for 
accurate detection of 5-500 pg/mL of IL-2 (1-step Ultra TMB ELISA, Thermo 
Scientific). After stopping the reaction with 2M sulfuric acid, absorbance was read at 
450nm. Absorbance levels were converted into amount of IL-2 based on a regression 
analysis of IL-2 standards using GraphPad Prism (GraphPad Software). To measure 
proliferation, CD4 T cells were isolated and cultured as in the IL-2 production assay. 
After 72 hours in culture at 37°C 5% CO2, each well was pulsed with 0.4µCi 3H 
thymidine and maintained in culture. After an additional 24 hours, plates were harvested 
and measured for 3H thymidine incorporation.  
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Ca2+ imaging and analysis 
Peptide loaded I-Ek dimers were plated on 8-chambered culture slides overnight in PBS. 
Slides were washed with Ca2+ free Ringer’s solution (150mM NaCl + 10mM glucose + 
5mM HEPES + 5mM KCl + 1mM MgCl2 + 2mM CaCl2, pH 7.4) prior to imaging. CD4 
T cells were isolated from n3.L2 and M2 TCR-tg mice and either cultured with irradiated 
B6.K splenocytes loaded with 10µM Hb antigen for 6 days to form T cell blasts or kept 
as naive cells at 37°C. To image Ca2+ fluxing, M2 and n3.L2 naive T cells or blasts were 
labeled in Ringer’s solution with 1µM Fura-2 AM, a Ca2+ specific indicator dye, 
immediately before imaging. 1x106 cells were resuspended in 1mL Ringer’s solution with 
1µM Fura-2 AM and incubated for 30 minutes at 37°C. Cells were washed 1x in 
Ringer’s, resuspended in Ringer’s, and quenched for 30 minutes at 37°C. Cells were 
added to washed wells of the chamber slide and imaged by transmitted light and for 
emission of 340 and 380 nm fluorescence at 3-second intervals for at least 30 minutes. 
Data was expressed as a 340/380 ratio to account for loading variation. Between imaging 
Rag+/+ and Rag1-/- T cells, the microscope underwent repairs and was recalibrated. The 
340/380 rations differ in levels as a result. While the values differ, the trends can be 
compared. 
 Images were analyzed using Metamorph. Regions were drawn around each 
responding cell (above background intensity ratio of 200) and tracked at each timepoint. 
Average and maximal intensities for each ratio were recorded for each timepoint in 
Excel. Maximal intensity for the entire time course was identified and tracks were aligned 
using an align program (written by E.A. Yttri, using R) to provide data sets for 
characterization of the Ca2+ flux pattern. Peak (max) intensity, average sustained intensity 
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(post peak), and oscillations (deviation from linear regression of post peak intensities) 
were compared by ANOVA using Graph Pad Prism.  
 
Generation of bone marrow chimeras 
Bone marrow was isolated from tibias and femurs of n3.L2 and M2 TCR transgenic mice. 
Bone marrow was flushed out using a syringe and culture media. Bone marrow 
homogenate was filtered to remove bone and other particulate or clumps. RBC were 
lysed using ACK lysis buffer, which does not lyse lymphocytes or precursors. 20 x106 
total bone marrow cells were injected i.v. into lethally irradiated recipients. Recipients 
were irradiated with 900 rad one day prior to bone marrow transfer. For mixed chimeras, 
106 n3.L2 and 106 M2 or B6.K control cells were mixed together and transferred into 
recipients. Mixed bone marrow was analyzed by flow cytometry to record the exact 
percent derived from each mouse type. Chimeras were maintained on antibiotic treated 
water for 8-12 weeks until tissues were collected and analyzed by flow cytometry. The 
initial sets of chimeras, using Rag+/+ donors, were analyzed after 8 weeks, according to 
protocols used previously in the lab. The Rag1-/- chimeras were analyzed at 12 weeks 
after recommendations from Takeshi Egawa. 
 
I-Ek Ig dimers 
I-Ek dimers were produced in Drosophila S2 cells, as previously described (150). Amino 
acid residues chosen for mutagenesis were located on the top of the α and β helices as 
potential TCR contact residues. To generate mutant I-Ek dimers, mutations were 
introduced into I-Ek constructs at one of 4 MHCα and 3 MHCβ residues chosen from a 
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subset of mutants expressed in CHO cells (164). Wildtype and mutant I-Ek-Ig dimer 
constructs were transfected into Drosophila S2 cells. Dimers were isolated from culture 
supernatants by binding to Protein A.  Dimers were exposed to acidic pH to remove the 
endogenous, weakly binding peptides and maintained in excess amounts of soluble 
peptide to substitute the desired peptide into the peptide binding groove. To assay the 
TCR:pMHC binding footprint, 96 well plates were coated overnight with Hb(64-76)-
loaded I-Ek Ig dimers. After 20 hours, plates were washed to remove unbound dimer,      
5 x 105 hybridomas were added, and activation was assayed  after 20 hours using the IL-2 
ELISA described above.  
 
Results 
 
Generation of M2 TCR transgenic mice 
To determine if increased kon affected T cell development and normal function of 
naturally occurring mature T cells, we generated an M2 TCR transgenic mouse. The 
n3.L2 TCR transgenic mouse has previously been described (79). Work generating 
retroviral bone marrow chimeras with M2 T cells suggested that M2 would be positively 
selected but not negatively selected in the presence of I-Ek on APCs (data not shown). 
M2 α and β chain constructs were coinjected into B6.K eggs. This initial implantation 
produced a low fecundity, with one mouse positive for the α chain out of 45 tested. 
Therefore, the M2 TCR α and β transgenes were coinjected onto the B6 background. One 
founder was generated that co-expressed the M2α and β chains. A second founder was 
generated that expressed only the M2α chain. The M2α mouse was crossed to mice 
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expressing the n3.L2 β chain, which is common between the n3.L2 and M2 TCRs. The 
M2α/n3.L2β did not transmit the transgenes to offspring and therefore was not used 
further. The M2αβ founder was the source for all M2 mice used in these experiments. 
The M2αβ founder was crossed to the B6.K and B6.K/Rag1-/- background to provide the 
proper selecting environment for M2 T cells and to eliminate any potential complications 
from secondary TCRα rearrangements. The n3.L2 mouse was simultaneously crossed to a 
Rag1-/- background. The thymocytes and T cells of Rag+/+ and Rag1-/- mice were 
analyzed by flow cytometry. 
 
M2 CD4 T cells on a Rag+/+ background are mature but express low TCR levels 
 M2 T cells were present in the periphery of the M2 TCR transgenic mice (Figure 
3.1A). While these T cells had the same level of CD4 and CD3 (Figure 3.1A, B), M2 
CD4+ T cells had lower levels of TCR, measured by our clonotypic antibody, CAb. 
Additionally while the total spleen size was the same, the M2 mouse had a significant 
reduction in the CD4 population (Table 3.1). The CAb high population in the M2 mouse 
was depleted, suggesting the reduced population size was due to removal of the TCR 
high population. Other maturation markers, such as PD-1, CD5, CD62L and CD44, were 
expressed at the same level on M2 and n3.L2 transgenic CD4 cells (Figure 3.1B). There 
did not appear to be any skewing in other lymphocyte populations (B cells, NK cells, 
Tregs, γδ T cells). 
 In the thymus, the M2 CD4 SP population was reduced (Figure 3.2A) and also 
had a lower percent of TCR high cells (Figure 3.2B). Interestingly, fewer of these T cells 
were CD69+ than the same CD4 SP population in the n3.L2 mouse but otherwise there 
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was no difference in surface marker expression (Figure 3.2B). While there did not appear 
to be drastic skewing in the M2 thymus, the DP population was significantly reduced and 
the DN population significantly larger than in the n3.L2 mouse (Table 3.1). Aside from 
the lower TCR level, the DP populations were phenotypically the same between the two 
transgenic mice (Figure 3.2C). The M2 DN population had a slight increase in the CD25+ 
CD44- DN3 population (Figure 3.3A). The M2 DN thymocytes were able to express the 
transgenic TCR, similar to the n3.L2 DN thymocytes, indicating no block in selection of 
the Vβ8.3 TCRβ chain (Figure 3.3B).  
 
M2 CD4 T cells on a Rag1-/- background undergo negative selection 
Mature CD4+ T cells developed and were present in the periphery of the M2 Rag1-/- 
transgenic mouse (Figure 3.4A). These cells were completely mature and expressed high 
levels of TCR, CD3, CD4, and other maturation markers (Figure 3.4B).  However, the 
CD4+ cell number was greatly reduced in the M2 Rag1-/- mouse in comparison to n3.L2 
(Table 3.1), like was seen in the Rag+/+ TCR transgenic mouse. The decreased CD4 
population suggested a difference in T cell selection. In the thymus, both the M2 Rag1-/- 
and n3.L2 Rag1-/- mice had a mature CD4 SP population (Figure 3.5A). The CD4 SP 
populations expressed the same levels of TCR, CD4, CD3 and some maturation markers 
(Figure 3.5B). Very few Treg cells developed from the transgenic T cells either in the 
thymus or by peripheral conversion (Figure 3.6). There was no detectable γδ TCR 
expression (Figure 3.6). 
M2 Rag1-/- mice had dramatically reduced thymus cellularity in comparison to 
n3.L2 Rag1-/- (Table 3.1), suggesting a difference in T cell selection. The M2 Rag1-/- 
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thymus had an increased proportion of DN cells (Table 3.1), arrested at the DN3 stage of 
development (Figure 3.5, Figure 3.7A). While this developmental block indicated 
inefficient selection of the M2 TCR, the transgenic Vβ8.3 was highly expressed on a 
small population at the same level as in the n3.L2 Rag1-/- mouse (Figure 3.7B). The same 
TCRβ chain was expressed on a larger population in the n3.L2 mice (Figure 3.7B), 
suggesting the TCRβ transgene is not efficiently expressed in the M2 Rag1-/- mouse, 
blocking a large percentage of the M2 thymocytes at DN3. The DN population that does 
express Vβ8.3 developed into DP, SP, and peripheral T cells, permitting further analysis 
of those populations. Due to the increased DN population in the M2 Rag1-/- transgenic 
mouse, the number and percentage of DP thymocytes was also reduced in comparison to 
the n3.L2 Rag1-/- transgenic mouse (Table 3.1). In spite of fewer DP cells, the M2 Rag1-/- 
and n3.L2 Rag1-/- mice had the same proportion of CD4 single positive cells. Therefore, 
despite alterations in selection, M2 CD4+ T cells developed and persisted in the periphery 
in M2 Rag1-/- mice. While these cells appeared to be phenotypically normal, we predicted 
the consequences of a higher affinity interaction with endogenous pMHC in the thymus 
would alter CD4 function in response to cognate antigen. 
 
M2 Rag+/+ T cells failed to sustain activation, potentially as a result of earlier initiation 
of signaling 
Following recognition of agonist pMHC, CD4 T cells are programmed to secrete IL-2 
and proliferate. IL-2 production occurs rapidly after initiation of signaling cascades 
downstream of the TCR (165). Proliferation is a later consequence, usually occurring 
within days following antigen stimulation. Since the M2 TCR had a faster kon for binding 
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Hb(64-76)/I-Ek, the timing of signaling events may be shifted to favor an earlier onset. To 
test this hypothesis, CD4+ T cells were isolated from n3.L2 and M2 Rag+/+ mice and 
cultured in vitro with Hb pulsed irradiated B6.K splenocytes. Cell cultures were pulsed 
with 3H after 24 or 72 hours to measure T cell proliferation. Cultures were harvested 20 
hours later to assess 3H incorporation, indicating level of proliferation. IL-2 production 
by n3.L2 and M2 T cells was the same 20 hours post incubation. Proliferation of n3.L2 
and M2 T cells 48 hours post incubation was equivalent (Figure 3.8A). Interestingly, 
while n3.L2 T cells continued to proliferate 4 days after exposure to antigen, the M2 cells 
had reduced levels of proliferation at this timepoint (Figure 3.8B). This suggests that the 
faster kon of M2 T cells recognizing Hb(64-76)/I-Ek is of sufficient affinity to overcome 
the threshold for activation but either alters prolonged levels of signaling or results in 
earlier onset of activation followed by T cell burnout.  
 
M2 Rag1-/- T cells are hyporesponsive to Hb(64-76) in the periphery 
The immune system has developed multiple mechanisms to ensure self tolerance in the 
periphery in order to prevent autoimmunity. High affinity T cells that escape negative 
selection become unresponsive in the periphery (7, 166). Induction of anergy can be 
programmed in the thymus by selection or conferred by stimulation in the periphery (131, 
167, 168). Exposure to low affinity APLs either in the thymus or periphery results in 
suboptimal activation of T cells and failure to proliferate. Isolated M2 and n3.L2 Rag1-/- 
CD4+ T cells had the same sensitivity in producing IL-2 in response to Hb(64-76)-I-Ek 
presented on irradiated B6.K splenocytes after 18-20 hours of culture (Figure 3.9A); 
however, the M2 T cells produced significantly lower levels of IL-2 in comparison to 
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n3.L2 T cells. Interestingly, isolated M2 Rag1-/- T cells failed to proliferate at day 4 in 
response to Hb(64-76) stimulation in contrast to the strong proliferation of n3.L2 T cells 
(Figure 3.9B). The reduced ability to produce IL-2 and inhibition of proliferation is a 
classic pattern of T cell anergy (8).  
An anergic state is often accompanied by downregulation of the TCR or 
costimulatory molecules on the T cell surface (130). M2 and n3.L2 T cells retained high 
TCR levels in the periphery of the transgenic mice (Figure 3.4). CD3 and CD4 levels 
were the same on n3.L2 and M2 cells (Figure 3.4), suggesting the unresponsive nature of 
M2 T cells is not due simply to low TCR and CD4 levels. Levels of CD25 (IL-2R), 
CD28, PD-1, and CTLA-4 were also similar on n3.L2 and M2 CD4 cells (Figure 3.4). As 
the induction of anergy did not appear to be due to decreased costimulation or increased 
inhibitory signals, M2’s hyporesponsive phenotype may be set in the thymus as a result 
of different T cell selection in comparison to n3.L2. 
 
Early signaling is maintained but differs downstream of the M2 and n3.L2 TCRs 
While the proliferative response of M2 T cells to agonist peptide was inhibited, T cells 
that are rendered anergic may maintain early signaling events. One of these early 
signaling responses is a flux of Ca2+ inside the cell. To measure the intracellular Ca2+ 
flux, we labeled isolated M2 and n3.L2 T cells with the ratiometric dye Fura-2 AM and 
imaged their response to plate bound Hb(64-76)/I-Ek dimers. Interestingly, the percentage 
of responding cells was the same for n3.L2 and M2 T cells. However, the characteristics 
of the Ca2+ signal differed. CD4 T cells isolated from the Rag+/+ transgenic mice differed 
in their sustained signal, with the n3.L2 T cells having a higher level post peak Ca2+ spike 
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(Figure 3.10). The interactions that n3.L2 T cells made with the I-Ek dimers promoted a 
more sustained signal. When Rag1-/- cells were used, the M2 and n3.L2 T cells differed in 
the oscillatory nature of the signal after the initial Ca2+ spike (Figure 3.11). M2 Rag1-/- T 
cells had more variation in the level of Ca2+ post peak, measured as deviation from a 
predicted linear regression. Taken together, the differences in Ca2+ fluxes in n3.L2 and 
M2 T cells suggests that the kinetics of TCR interactions with agonist pMHC are tuned to 
sustain signals in the T cell and changes in kon of the interaction result in qualitatively 
different signaling patterns. By altering the cascades downstream of the TCR, M2 T cells 
can be rendered anergic.  
 
Stronger selection signal sensed by M2 expressing thymocytes 
T cell selection in the thymus is dependent upon recognition of endogenous pMHC by the 
TCR. A T cell that receives a strong signal during selection can be targeted for anergy if 
not deleted by negative selection. We hypothesized that M2 thymocytes would be more 
sensitive to signals from endogenous selecting pMHCII as a consequence of a lower 
threshold for selection due to M2’s faster kon. The level of CD5 is proportional to the 
strength of signal through the TCR during positive selection (169). The M2 Rag1-/- CD4 
SP cells had higher surface levels of CD5 in comparison to n3.L2 Rag1-/- CD4 SP cells 
(Figure 3.12A). The CD5 level was the same on CD4 SP cells in the M2 and n3.L2 
Rag+/+ mice (Figure 3.2), which could be a consequence of selection based on a second 
TCR expressing a non transgenic α chain. CD69 is upregulated on the surface of DP 
thymocytes that have received a selection signal (152). Since the fate of DP thymocytes 
that upregulate CD69 post selection is variable, we tested the ability of n3.L2 and M2 
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thymocytes to recognize self-peptides in vitro. DP thymocytes isolated from n3.L2   
Rag1-/- and M2 Rag1-/- transgenic mice were cultured with irradiated B6.K splenocytes 
without the addition of peptide and assayed for CD69 upregulation by flow cytometry. 
After 18 hours in culture, a larger percentage of M2 Rag1-/- DP thymocytes were CD69+ 
(Figure 3.12B), indicating these cells recognized endogenous peptides presented by the 
B6.K APCs (74) that were not recognized by n3.L2 DP cells. The higher CD5 level on 
M2 Rag1-/- SP cells combined with more DP thymocytes upregulating CD69 in response 
to endogenous antigen suggest a stronger affinity for self pMHC. Therefore, the 
mutations resulting in the increased affinity of the M2 TCR for Hb(64-76)-I-Ek may also 
raise the affinity of M2 for self pMHC and produce stronger signaling through the TCR. 
A subset of high affinity T cells developing in the thymus upregulate expression of 
FoxP3. These Tregs develop in response to a strong interaction with self-peptides that does 
not result in negative selection (170). There was no increase in the percentage of FoxP3+ 
Tregs in the n3.L2 or M2 mice (Figure 3.6) indicating that while the affinity of the M2 
TCR for self-peptide may be stronger than for n3.L2, the transgenic TCR does not 
promote development of Tregs. We attempted to identify a self-peptide that differentially 
selected n3.L2 and M2 thymocytes. We screened 95 self-peptides for their ability to 
upregulate CD69 on M2 and n3.L2 DP thymocytes but were unable to find any 
stimulatory peptides (data not shown). This was not surprising as peptides involved in 
positive selection are highly specific (74). Even so, the CDR1α mutations in the M2 TCR 
may lessen the energetic requirement for sufficient contact with endogenous pMHC. This 
would increase the level of positive selection of M2 thymocytes through stronger affinity 
interactions or by increasing the number of positively selecting peptides, as was seen with 
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the Hb(64-76) APLs (Figure 2.11). However, the increased strength of signaling through 
the M2 TCR might be above the threshold for negative selection, resulting in elimination 
of these strongly responding T cells. What is most intriguing is that the M2 TCR retained 
an affinity well within the reported normal range of TCRs binding antigen. The specific 
change of kon in the M2 system could account for this incongruity, suggesting T cell 
selection is more sensitive to kon than previously thought.  
 
M2 T cells are deleted when exposed to Hb(64-76) as an endogenous peptide 
In addition to testing the thymocyte response in vitro, we wanted to measure 
selection changes in response to Hb(64-76) as an endogenous ligand. A strong signal 
during T cell selection can result in deletion of T cells by negative selection (78, 128). 
This theory correlates well with the reduced peripheral CD4 population in the M2 
transgenic mouse. We took advantage of the mouse Hb antigen system to directly 
examine selection of M2 and n3.L2 T cells in vivo in response to Hb(64-76) as an 
endogenous self-peptide. Neither T cell was reactive to Hbs (data not shown). A 
B6.K/Hbd congenic line was bred to the n3.L2 and M2 Rag+/+ TCR transgenic mice. Due 
to the high level of agonist antigen present in these mice, we predicted that n3.L2 and M2 
T cells would be deleted by negative selection. Surprisingly, a small number of n3.L2 
Rag+/+ CD4+ T cells were present in the periphery of the n3.L2 x Hbd mice (Figure 
3.13A). While some specific T cells were deleted due to recognition of Hbd(64-76) as 
self-peptide, the n3.L2 affinity for Hbd(64-76) was apparently not above the threshold for 
complete negative selection. By 4 weeks of age, these mice developed autoimmune 
hemolytic anemia as measured by the presence of anti RBC antibodies (Figure 3.13B). In 
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the n3.L2 x Hbd mice, we suggest that the small population of Hb specific T cells induce 
production of anti-Hbd antibodies by B cells in the spleen. Antibodies are then deposited 
on RBCs resulting in their lysis and the mice develop autoimmune hemolytic anemia. We 
can use antibody labeling of RBCs as readout for onset of anemia.  
In contrast to the n3.L2 x Hbd mice, the M2 x Hbd mice completely lacked M2 
specific cells in the periphery, though CAb+ cells were found in the thymus (Figure 
3.13A). M2 x Hbd mice failed to develop anemia due to complete elimination of the M2 
population (Figure 3.13B). While the percentage of CD4 cells found in the periphery of 
M2 x Hbd mice was not different from non-transgenic controls, a population below 
detection by CAb could still be present. In this case, the M2 CD4 T cells must be 
anergized as hemolytic anemia did not develop up to 10 weeks of age. An anergic 
phenotype would be consistent with stimulation results of CD4 T cells from the            
M2 Rag1-/- mice since these T cells failed to proliferate in response to Hb(64-76). In the 
M2 Rag1-/- mouse some M2 T cells escape negative selection (Figure 3.4A), whereas in 
the M2 x Hbd mouse they are completely eliminated (Figure 3.13A). Thus, the affinity of 
M2 for Hb(64-76)/I-Ek is above the negative selection threshold while the affinity of M2 
for endogenous pMHCII must be at or slightly below the limit for negative selection. 
 
Development of n3.L2 and M2 T cells in mixed bone marrow chimeras does not reveal 
competition between the two TCRs 
Restriction of the TCR rearrangement changes the development of the T cell repertoire. 
To compare development of n3.L2 and M2 T cells in the same mouse, we generated 
mixed bone marrow chimeras. Bone marrow cells were isolated from the congenically 
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marked n3.L2 and M2 TCR transgenic mice, combined 1:1, and injected intravenously 
into lethally irradiated recipients. After 8-12 weeks, development of n3.L2 and M2 T 
cells was assessed in the thymus and periphery of chimeras. When Rag+/+ bone marrow 
was used to reconstitute chimeras, both n3.L2 and M2 T cells were found in the thymus 
and periphery of the mixed chimeras (Figure 3.14). Interestingly, the CAb high, CD4 SP 
population was derived solely from the n3.L2 bone marrow. In contrast, the majority of 
the CAb low population developed from M2, with a reduced proportion from n3.L2. The 
TCR high population that develops expressing the M2 TCR was eliminated from the 
bone marrow chimeras. This same population was missing in the M2 Rag+/+ transgenic 
mouse. CD4 T cells in the n3.L2 Rag+/+ transgenic mouse express high levels of the 
transgenic TCR. Therefore, there did not appear to be any competition between 
development of n3.L2 and M2 T cells.  
 Since development of M2 T cells differed between the Rag+/+ and Rag1-/- 
backgrounds, mixed bone marrow chimeras were generated using bone marrow isolated 
from the n3.L2 and M2 Rag1-/- transgenic mice. The CAb+ CD4 population in the spleen 
developed primarily from the n3.L2 bone marrow (Figure 3.15). Less than 6% developed 
from M2 bone marrow. Initially the low percent of M2 expressing T cells suggested that 
the n3.L2 TCR was preferentially selected over the M2 TCR. In fact, the percentage of 
M2 cells developing in the mixed bone marrow chimeras was lower than in chimeras 
using only M2 bone marrow (Table 3.2). However, the percent and number of M2 
progenitors in the DP population was also decreased in the mixed chimeras. By 
calculating the predicted percentage of M2 cells based on the DP population, the low 
percentage of M2 CD4 T cells that develop was the same as predicted by the DP 
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breakdown (Table 3.2). Therefore, the presence of developing n3.L2 T cells did not 
influence the development of M2 CD4 T cells and vice versa.  
 
In vivo activation of n3.L2 and M2 CD4 T cells leads to development of anemia, though 
with different disease kinetics 
When the TCR transgenic mice were crossed to express Hbd endogenously, both n3.L2 
and M2 T cells were depleted. An alternative way to test induction of anemia involved 
transferring T cells into Hbd Cα-/- mice. Transfer of antigen specific T cells into 
lymphoreplete mice as has been used to study induction of arthritis (171), diabetes (172), 
and experimental autoimmune encephalitis (173) without suppressive signals from Tregs 
or complication of endogenous T cells. Interestingly, both n3.L2 and M2 T cells induce 
anemia and mice eventually succumb to the disease (Figure 3.16). By transferring M2 T 
cells into a lymphopenic environment, these CD4 T cells are rescued from a tolergenic 
state and able to activate in response to the endogenous Hbd. A similar phenomenon was 
recently reported for tolerized CD8+ T cell that developed in the presence of cognate 
antigen and gained activity when transferred into irradiated, lymphopenic recipients 
(174). Given this scenario, both the n3.L2 and M2 T cells undergo homeostatic 
proliferation to fill the T cell niche. The presence of the Hbd antigen would enhance 
proliferation and generate a sufficient T cell population to amplify production of anti 
RBC antibodies by B cells and exacerbate disease. In the GAG system, CD8 T cells were 
retolerized when endogenous T cells returned (174). This could explain why induction of 
anemia fails in the Hbd Cα+/+ recipients. In the presence of endogenous T cells, including 
Tregs, the transferred transgenic CD4 T cells would be unable to proliferate either through 
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competition for proinflammatory signals or the presence of suppressive ones. While both 
n3.L2 and M2 T cells perpetuate anemia, the M2 T cells have a delay in both detection of 
anti RBC antibodies and in eventual death of recipients (Figure 3.16). Since the n3.L2 T 
cells are fully functional when isolated from the transgenic mouse, it seems the M2 T 
cells require two additional days to recover from their tolerized state and respond to the 
endogenous Hbd. It was not determined if there are additional differences in the 
phenotype or course of disease development. 
 
CDR1α of M2 stabilizes the TCR to maintain activation despite mutations in the MHCIIα 
chain 
We wanted to begin to understand the structural basis for how changing the kon for 
TCR:pMHC could result in the dramatic changes seen in the M2 CD4 population. The 
CDR1 loop can interact with the MHC molecule, sometimes without directly contacting 
the peptide itself. Changes in the CDR1α loop could alter the orientation or direct 
interactions between TCR:pMHC. We used a set of mutant I-Ek dimers, each containing a 
single amino acid substitution at a potential TCR contact site, to measure changes in the 
TCR:pMHCII binding footprint (164). Mutant I-Ek dimers were loaded with Hb(64-76) 
peptide and used to stimulate IL-2 production by the n3.L2 and M2 hybridomas. 
Mutations that completely inhibited IL-2 production (> 80% reduction) were considered 
critical for the TCR:pMHCII interaction. All 3 mutations in the MHCIIβ chain 
completely inhibited IL-2 secretion for both n3.L2 and M2 hybridomas (Figure 3.17) 
suggesting interactions with the MHCIIβ are highly specific and critical for formation of 
the TCR:pMHCII complex. The n3.L2 hybridomas failed to recognize α53, α55, and α57 
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mutations, indicating these MHCIIα residues are critical for the n3.L2 interaction (Figure 
3.17). Interestingly, M2 hybridomas maintained stimulation by all MHCIIα chain 
mutants. Therefore the n3.L2 TCR contact with the MHCIIα mutants was below the 
threshold for IL-2 production while the M2 CDR1α mutations maintained sufficient 
affinity to overcome the activation threshold. It is unclear whether the enhanced affinity 
dictated by CDR1α is directly through generation of new contacts or through enhanced 
interactions with key amino acid residues.  
 
Discussion 
 
The role of kon in influencing signaling outcomes of specific TCR:pMHC 
interactions has previously been suggested but not directly determined. Ours is the first 
system to measure the effect of specifically changing the kon in vitro and in vivo, without 
compensatory changes in koff. Here we show that an increased kon significantly affects T 
cell selection and activation. The M2 TCR has a 3.7 fold higher affinity for Hb(64-76)/I-
Ek than n3.L2 due to a faster kon. As a consequence, signaling through the transgenic 
TCR is stronger in M2 DP thymocytes, indicated by higher CD5 levels and increased 
CD69 upregulation than on n3.L2 thymocytes. Because of a higher affinity for 
endogenous pMHCII, M2 thymocytes are subjected to increased negative selection. In 
the M2 Rag+/+ mouse, the M2 CD4 T cells proliferate early after activation but fail to 
sustain the response. When these T cells are restricted to selection on the transgenic TCR, 
the few CD4 cells that escape negative selection in M2 Rag1-/- mice are hyporesponsive 
to Hb(64-76)/I-Ek stimulation. Similarly M2 and n3.L2 CD4 T cells differ in the pattern 
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of Ca2+ flux, suggesting that the difference in selection of M2 and n3.L2 T cells in the 
thymus alters signaling downstream of the TCR in the periphery. When Hbd is presented 
as an endogenous antigen, M2 expressing CD4 T cells are completely deleted by negative 
selection whereas a small population of n3.L2 cells escape to the periphery and cause 
autoimmune disease. The difference in selection and activation of M2 cells is likely a 
consequence of either new or enhanced contacts with the MHCII, as a result of the 
CDR1α mutations that drive M2’s faster kon and an overall stronger affinity for MHCII.  
It remains to be seen if kon merely fine-tunes TCR recognition of pMHC, 
potentially optimizing signaling through the TCR, or if altering kon affects generation of 
T cell effector and memory cells in the periphery. By increasing kon, we generated a T 
cell that is tolerized to the point of anergy due to increased recognition of pMHCII. While 
this phenotype is not unique, it is unclear how a faster kon induces anergy. What is unique 
about our system is that the M2 TCR has a higher affinity due to two amino acid changes 
in the CDR1α loop. The CDR3 loops interact with the peptide, conferring the cross-
reactive property of T cells, and therefore have been the main focus in determining what 
makes a T cell potentially autoreactive (37, 38, 175). With M2, mutations in the CDR1α 
loop not only generate a higher affinity TCR (29) but also regulate activation through the 
TCR. The stability of the TCR or the TCR:pMHC complex conferred by the CDR1α 
mutations may maintain an affinity closer to the threshold for T cell activation. As a 
result, M2 T cells can potentially recognize a larger number of selecting peptides in the 
thymus. While the CDR1α loop is very flexible (33), we cannot determine if changes in 
peptide fine specificity are due to greater flexibility or merely the result of stronger 
affinity interactions. 
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 The increased level of negative selection of M2 cells may be a consequence of 
broader recognition of selecting peptides or stronger interactions with self-peptides that 
select n3.L2. By increasing the affinity of the TCR for self pMHC complexes, peptides 
which were low affinity, inducing positive selection, would have high enough affinity to 
overcome the threshold for negative selection. Therefore, the CDR1α mutations that 
increased the kon for the M2 TCR may in fact be generating a TCR with stronger 
recognition of MHCII in the thymus. While we were unable to identify a positively 
selecting peptide, this does not disprove M2’s higher affinity for endogenous pMHCII, as 
positively selecting peptides are highly specific and do not reflect the structural features 
of agonists (70, 73-75). High affinity TCRs that escape negative selection are potentially 
selected using different binding conformations from those used for recognition of antigen 
in the periphery (38). Inherent TCR flexibility is an effective mechanism for generating a 
sufficient T cell repertoire to target infections and tumors but can go awry generating 
autoimmunity (10, 21).  
 As a mechanism to prevent autoimmune disease, high affinity TCRs can be 
tolerized, leaving a population of autoreactive T cells unresponsive to agonist stimuli. M2 
T cells develop in an environment lacking the Hbd agonist peptide and do not respond to 
Hbs stimulation (data not shown), both indicators that M2 (and n3.L2) T cells are unlikely 
to become autoreactive in the transgenic mouse. Even so, the TCR high population is 
deleted from the M2 Rag+/+ mouse presumably due to increased negative selection. Those 
cells that escape negative selection in the M2 Rag1-/- mice are anergized in the periphery. 
Since M2 T cells are not above physiological affinity for pMHCII, the 4µM affinity may 
reflect a maximal level of CD4 responsiveness, as has been seen with CD8 cells (176). 
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Weak agonist TCR:pMHC interactions, such as is measured with some APLs, often result 
in incomplete T cell activation and induction of anergy (5, 6, 8, 110, 131, 133). 
Rechallenge with an agonist after anergy induction by APL stimulation leads to an 
inability to proliferate but restored IL-2 production both in vitro and in vivo (124). M2 T 
cells that escape negative selection following selection by a weakly stimulatory peptide 
would be hyporesponsive when exposed to Hb(64-76) agonist. Early signaling events 
downstream of the hyporesponsive M2 TCR may be insufficient to trigger full IL-2 
production and proliferation, as has been seen with cytolytic activity of CD8 T cells 
(177), but maintain early signaling events such as Ca2+ (108, 110). The developmental 
programming imposed on these cells in the thymus leads to an altered and attenuated 
response, despite the sufficient affinity for full activation by an agonist peptide. 
 The signaling program downstream of the TCR is clearly different between n3.L2 
and M2 CD4 T cells. Upon recognition of Hb(64-76)/I-Ek the n3.L2 T cells can respond 
with full T cell activation leading to sustained Ca2+ levels inducing strong IL-2 
production and proliferation. M2 CD4 T cells produce low IL-2 and fail to proliferate 4 
days after exposure to antigen. Ca2+ is a critical second messenger of signal transduction 
in the T cell and the strength and sustained level of Ca2+ signaling can differentially 
activate transcription factors (178). Interestingly, the pattern of intracellular Ca2+ levels 
can regulate the induction of T cell anergy. A sustained Ca2+ signal with low-level 
oscillations is required for NFAT dephosphorylation leading to transcription of cytokines 
such as IL-2 (179). Alternatively, tolerizing signals, such as in the absence of 
costimulation or due to ionomycin treatment, lead to unregulated increases in intracellular 
Ca2+ and formation of NFAT homodimers which can induce transcription of proteins that 
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suppress IL-2 production and T cell proliferation leading to an anergic phenotype (180, 
181). A similar genetic program could be induced with suboptimal stimulation, such as 
with an antagonist APL. The features of productive versus suppressive Ca2+ signaling 
may reflect the differences between signals measured in n3.L2 and M2 CD4 T cells. 
Uncovering this level of genetic regulation during selection of the M2 T cells would give 
further credence to the role development plays in peripheral T cell response.  
 The optimized M2 TCR structure has a faster kon for binding Hb(64-76) I-Ek. The 
CDR1α region stabilizes the TCR with pMHC by contributing energetically to the 
overall complex as a result of contact with MHC or directly influencing the CDR3α 
contact with peptide (22, 32, 33). Since mutations on the I-Ek α chain maintained 
sufficient interaction with M2 for IL-2 production but not n3.L2, the M2 CDR1α 
mutations may result in new or stronger contacts with the MHCII, decreasing the 
requirement for others. An altered binding footprint is unlikely, as structures of high 
affinity variants in the 2C system do not show altered footprints (182). Instead the faster 
kon of M2 binding pMHC may reflect an optimal conformation for association with 
MHC, maintaining affinity above the threshold for T cell activation with a broad range of 
peptides. A crystal structure of the M2: Hb/I-Ek co-complex would identify the exact 
structural changes induced by the M2 CDR1α mutations. While the CDR1α mutations 
increase the kon for M2:Hb(64-76)/I-Ek, productive signaling through the TCR is 
dampened during T cell selection. Therefore, a strong affinity and sustained TCR:pMHC 
complex must be finely tuned, potentially by kon, to produce a mature and responsive T 
cell. 
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Figure 3.1 Characterization of the CD4 T cell populations in the periphery of n3.L2 
and M2 Rag+/+ TCR transgenic mice 
A. Flow cytometry analysis of populations in the spleen of n3.L2 (left) and M2 (right) 
Rag+/+ TCR transgenic mice. The clonotypic antibody, CAb, was generated against the 
n3.L2 TCR and labels both n3.L2 and M2 expressing cells. Plots were gated on live 
lymphocytes. The percentage of specific transgenic CD4 (CAb+ CD4+) cells in the 
lymphocyte population is noted on each dot plot. Plots are representative of 10 mice. B. 
Overlays of CD4+ CAb+ populations shown in A in the spleen of representative n3.L2 
(black) and M2 (histograms) mice.   
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Figure 3.2 Characterization of Rag+/+ TCR transgenic thymus populations 
A. Labeling of representative thymus from age matched n3.L2 (left) and M2 (right) 
Rag+/+ transgenic mice for CD4 and CD8 expression. Percentage of DN, DP, CD4 and 
CD8 SP populations are listed. n = 10 mice for each group. B.  Analysis of the CD4 SP 
populations from A. Shown percentages are for CAb high and CAb low populations from 
n3.L2 (left) and M2 (right) mice. Representative overlays of surface levels of activation 
and selection markers are for the full CD4 SP population for n3.L2 (black histogram) and 
M2 (filled histogram). C. Analysis of DP thymocytes gated in A for the CAb populations 
shown in B, CD3 and CD69 for n3.L2 (black histogram) and M2 (filled histogram) mice.  
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Figure 3.3 Analysis of DN populations in the M2 Rag+/+ transgenic mouse 
A. Characterization of DN populations shown in Figure 3.2A. Percentage of DN1, DN2, 
DN3 and DN4 populations are shown (top) for n3.L2 (left) and M2 (right) Rag+/+ mice. 
Level of TCR expression, measured by CAb, on total DN cells is noted on bottom plots. 
B. Overlay of TCRβ chain expression on DN cells from n3.L2 (black histogram) and M2 
(filled histogram) mice. 
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Figure 3.4 Characterization of the CD4 T cell populations in the periphery of n3.L2 
and M2 Rag1-/- transgenic mice 
A. Flow cytometry analysis of the transgenic CD4 population in the spleens of age 
matched n3.L2 (left) and M2 (right) transgenic mice. CAb labels both n3.L2 and M2 
expressing cells. Plots were gated on live lymphocytes. The percentage of specific 
transgenic CD4 (CAb+ CD4+) cells in the lymphocyte population is noted on each dot 
plot. Representative plots from 10 mice. B. Histogram overlays showing TCR, CD3, CD4 
and maturation markers on naive cells from the spleen of n3.L2 (black line) and M2 
(filled histogram) TCR transgenic mice. Splenocytes were gated on live lymphocytes 
followed by CAb+ CD4+ cells.   
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Figure 3.5 Characterization of thymocytes in n3.L2 and M2 Rag1-/- transgenic mice 
A. Labeling of representative thymus from age matched n3.L2 (left) and M2 (right) 
transgenic mice for CD4 and CD8 expression. Percentage of DN, DP, CD4 and CD8 SP 
populations are listed. n = 10 mice for each group. B. Overlays of TCR, CD3, CD4, 
CD25 and CD44 levels on gated n3.L2 (black line) and M2 (filled histogram) CD4 SP 
populations from panel A.  
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Figure 3.6 Development of alternative T cell populations in n3.L2 and M2 Rag1-/- 
mice 
Expression of FoxP3 in thymus and spleen CD4 cells. Plots were gated on CAb+ CD4 SP 
cells and assayed for CD25 and FoxP3 levels. Gates were determined based on B6.K 
control populations, which have a normal Treg population. Representative plots from 5 
mice in 3 independent experiments. The same gating scheme was used to measure the 
FoxP3+ population in the spleen of the n3.L2 and M2 TCR transgenic mice. As no CD25+ 
cells were identified, shown gates are for the FoxP3+ population. Levels were equivalent 
to negative control labeling, indicating the few FoxP3 cells detected are due to non-
specific antibody labeling. γδ T cells did not develop in the n3.L2 (black) or M2 (filled) 
transgenic mice, indicating the transgenic TCRs are specific for development of CD4+ αβ 
T cells. Representative plots from 5 mice in 3 independent experiments.  
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Figure 3.7 TCRβ is expressed in n3.L2 and M2 Rag1-/- DN thymocytes 
A. Analysis of the DN population from the thymus plot and gating shown in Figure 3.5. 
The M2 TCR transgenic mouse had a large population of CD25+ CD44- cells. B. 
Intracellular staining for the transgenic Vβ8.3 TCRβ chain. N3.L2 (black) and M2 
(filled) DN cells expressed equivalent levels of Vβ8.3, though the population of TCRβ+ 
cells was reduced in the M2 TCR transgenic mouse. The n3.L2 (black) and M2 (filled) 
CD4 SP populations all expressed high levels of the TCRβ chain. Representative plots 
from 5 mice in 3 independent experiments.  
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Figure 3.8 M2 Rag+/+ CD4 T cells proliferate 2 days after culture with Hb(64-76) but 
cannot sustain the proliferative response 4 days after culture 
A. CAb+ CD4+ cells isolated from n3.L2 (blue square) and M2 (green triangle) mice were 
cultured in triplicate overnight with irradiated B6.K splenocytes pulsed with indicated 
concentrations of purified Hb(64-76) peptide. Cultures were pulsed with 0.2µCi 3H and 
harvested 20 hours later. Dose curves are mean + SEM for 5 independent experiments. B. 
CAb+ CD4+ cells isolated from n3.L2 (blue square) and M2 (green triangle) mice were 
cultured with irradiated B6.K splenocytes pulsed with indicated concentrations of 
purified Hb(64-76) peptide for 72 hours. Cultures were pulsed with 0.2µCi 3H and 
harvested 20 hours later. Dose curves are representative mean + SEM for 2 independent 
experiments. 
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Figure 3.9 M2 Rag1-/- T cells produce IL-2 but fail to proliferate in response to  
Hb(64-76) 
A. CAb+ CD4+ cells isolated from n3.L2 (blue square) and M2 (green triangle) Rag1-/- 
mice were cultured in triplicate overnight with irradiated B6.K splenocytes pulsed with 
indicated concentrations of purified Hb(64-76) peptide. After 18-20 hours, IL-2 
production was assayed by ELISA. Dose curves are mean + SEM of triplicate samples 
from 3 independent experiments. B. The same cells assayed for IL-2 production in panel 
A were maintained in culture for 72 hours to measure proliferation of isolated n3.L2 
(blue square) and M2 (green triangle) cells by 3H incorporation. Dose curves are mean + 
SEM of triplicate samples from 3 independent experiments.  
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Figure 3.10 Ca2+ signal in Rag+/+ CD4 T cells from n3.L2 and M2 mice differ in 
sustained level 
Isolated CAb+ CD4+ cells from n3.L2 and M2 Rag+/+ mice were labeled with Fura-2 AM 
and imaged for Ca2+ in response to Hb(64-76) or MCC loaded I-Ek Ig dimers. Compiled 
results are from two independent experiments imaged in duplicate timelapses. Data were 
analyzed by identifying cell regions and measuring the peak (max) intensity of 340/380 
ratio, average intensity post peak intensity, and oscillatory behavior (standard deviation 
from linear regression modeling of post peak intensities). n = 38 for n3.L2 response to 
0.3µg/mL Hb (blue); n = 78 for M2 response to 0.3µg/mL Hb (green); n = 40 for 
response of n3.L2 and M2 to MCC. 
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Figure 3.11 Ca2+ signal in Rag1-/- CD4 T cells from n3.L2 and M2 mice differ in 
oscillatory behavior 
Isolated CAb+ CD4+ cells from n3.L2 and M2 Rag1-/- mice were labeled with Fura-2 AM 
and imaged for Ca2+ in response to Hb(64-76) or MCC loaded I-Ek Ig dimers. Compiled 
results are from two independent experiments imaged in duplicate timelapses. Data were 
analyzed by identifying cell regions and measuring the peak (max) intensity of 340/380 
ratio, average intensity post peak intensity, and oscillatory behavior (standard deviation 
from linear regression modeling of post peak intensities). n = 91 for n3.L2 response to 
0.3µg/mL Hb (blue); n = 41 for M2 response to 0.3µg/mL Hb (green); n = 63 for 
response of n3.L2 and M2 to MCC.  
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Figure 3.12 M2 thymocytes sense stronger selecting signals 
A. Overlay of CD5 levels on CD4 SP populations gated in Figure 3.5 from n3.L2 (black 
line) and M2 (filled histogram) Rag1-/- transgenic mice. Representative plots from 10 
mice. B. DP thymocytes isolated from n3.L2 (black) or M2 (grey) thymi were cultured 
for 18 hours with irradiated B6.K splenocytes. The mean + SEM percentage of DP cells 
that were CD69+ is presented.  p values determined by Student’s t test. n = 11 from 5 
independent experiments.   
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Figure 3.13 M2 T cells are negatively selected when exposed to endogenous Hbd and 
fail to induce anemia 
A. n3.L2 and M2 transgenic mice were crossed to congenic Hbd mice, which express the 
agonist Hbd (64-76) as a self-peptide. Thymi and spleens from the crosses were assessed 
for presence of CAb+ CD4+ cells. Percent CAb+ CD4+ shown for representative n3.L2, 
M2, n3.L2 x Hbd, M2 x Hbd, and transgenic negative Hbd littermate mice, aged 6 weeks. 
6 n3.L2 x Hbd and 6 M2 x Hbd mice were characterized for development of transgenic T 
cells. B. n3.L2 x Hbd and M2 x Hbd mice were monitored for development of anemia by 
deposition of antibodies on RBC. Peripheral blood from 5 week old n3.L2 x Hbd (black 
line) and M2 x Hbd (filled histogram) mice was labeled with a PE-pan Ig antibody. 
Overlays show levels of anti-Ig on gated RBCs for 3 n3.L2 x Hbd and 3 M2 x Hbd mice.  
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Figure 3.14 Chimerism in BMCMs using Rag+/+ transgenic donor bone marrow 
Bone marrow chimeras were generated by transferring bone marrow isolated from n3.L2 
Ly5.1 and M2 Thy1.1 Rag+/+ transgenic mice into irradiated B6.K recipients. Bone 
marrow was mixed at a 1:1 ratio from the two transgenics or each transgenic and B6.K 
bone marrow as controls. After 8 weeks, chimeric mice were analyzed for development 
of transgenic populations in the thymus and spleen using the CAb antibody. From the 
CD4 population, both CAb high and CAb low populations developed. The contribution of 
n3.L2 and M2 progenitors to CAb populations is indicated in gates. Plots are 
representative of n = 9 n3.L2 x M2; n = 7 n3.L2 x B6.K; n = 5 M2 x B6.K made at 3 
independent times.  
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Figure 3.15 Chimerism in BMCMs using Rag1-/- transgenic donor bone marrow 
Bone marrow was isolated from n3.L2 Ly5.1 and M2 Thy1.1 Rag1-/- mice and mixed at a 
1:1 ratio before being transferred into irradiated hosts. As a control, transgenic bone 
marrow was mixed with B6.K bone marrow. After 12 weeks, chimeric mice were 
analyzed for the development of CAb+ transgenic populations in the thymus and spleen. 
For DP, CAb+ CD4 SP, and splenic CAb+ CD4 populations, the percent derived from 
n3.L2, M2, or B6.K bone marrow is indicated. Plots are representative of n = 16 n3.L2 x 
M2 mixed chimeras; n = 7 n3.L2 x B6.K; n = 9 M2 x B6.K made in 3 independent sets.  
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Figure 3.16 Hbd Cα-/- mice succumb to anemia after transfer of n3.L2 or M2 CD4 T 
cells 
1 x 106 isolated CAb+ CD4+ T cells from n3.L2 and M2 mice were transferred into      
Hbd Cα-/- mice. Mice were monitored for death due to development of anemia as a 
consequence of transferred cells. n = 15 for transfer of M2 cells; n = 14 for n3.L2.   
p =0.04 for log-rank test of survival curves. 
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Figure 3.17 Characterization of the footprint of n3.L2 and M2 binding  
Hb(64-76)/I-Ek 
Plate bound Hb-loaded mutant I-Ek dimers were used to stimulate IL-2 production by 
n3.L2 and M2 hybridomas. We tested the response to 4 mutations in the I-Ek α chain and 
3 mutations in the I-Ek β chain. MHC residues were considered critical if mutation at that 
position inhibited >80% of IL-2 production. Critical contact residues are highlighted by 
red circles on a surface model of the crystal structure of Hb bound to I-Ek (Protein 
DataBank accession code, 1FNG). The MHCIIα mutation at position 64 did not alter IL-
2 production by n3.L2 or M2 and is not indicated on the model. Green ovals represent the 
general contact area for TCR CDR1α loops, where the two amino acid differences 
between n3.L2 and M2 are located. Summarized results are based on 3 independent 
experiments.   
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Table 3.1 Percentage of populations in the thymus and periphery of TCR transgenic 
mice 
Compilation of thymus and spleen populations in the n3.L2 and M2 transgenic mice. 
Plots were gated as in Figures 3.1-3.5 and percentages of each population were recorded. 
Shown is mean + SEM. p values determined by T-test comparing each population in the 
n3.L2 and M2 mice. n = 6 for n3.L2 Rag+/+; n = 14 for n3.L2 Rag1-/-; n = 11 for M2 
Rag+/+; n = 16 for M2 Rag1-/- 
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Table 3.2 Percentage of cell populations in bone marrow chimeras developing from 
n3.L2 and M2 Rag1-/- bone marrow 
Percentage of thymic and spleen populations derived from n3.L2 or M2 Rag1-/- bone 
marrow in chimeras after 12 weeks. Populations were gated as in Figure 3.15. n = 16 for 
n3.L2 x M2 mixed chimeras; n = 7 n3.L2 x B6.K; n = 9 M2 x B6.K. p values determined 
by Student’s T test comparing the mixed and single transgenic chimera percentages.  
  
135 
 
 
 
 
 
  
 
 
 
 
  
136 
 
 
 
CHAPTER 4 
 
Future Directions 
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Selection by antagonist and weak agonist APLs may alter signaling downstream of the 
TCR and dampen the peripheral T cell response 
M2 thymocytes had increased reactivity to APLs and self-peptides during 
selection, resulting in negative selection of M2 T cells. The most logical explanation is 
that the M2 TCR had a stronger affinity for self pMHC expressed on thymic epithelial 
cells as a consequence of a faster rate of association with pMHC. In the case of the M2 x 
Hbd mice, transgenic T cell development may be skewed by the high level of agonist 
antigen in the thymus, exacerbating the level of negative selection by other endogenous 
peptides alone. This system cannot differentiate between the signals from the high 
affinity of one TCR:Hbd interaction versus integration of signals from multiple, different 
TCR:pMHC interactions, an important distinction when evaluating a kinetic model for T 
cell selection. Decreasing the amount of Hbd available to developing TCRs by further 
crossing the M2 x Hbd mice to B6.K would identify if the high level of negative selection 
is a consequence of the small M2 population or due specifically to the kinetics of 
TCR:Hbd/I-Ek interaction, as has previously been suggested (78).  
Based on the function of peripheral M2 CD4 T cells and the increased thymocyte 
sensitivity to APLs and endogenous peptides, the developmental skewing of M2 T cells is 
most likely the consequence of exposure to an antagonist ligand in the thymus. While 
antagonists in the periphery will dampen a specific response to agonist antigen, in the 
thymus these same APLs can be recognized as selecting peptides. Previously, mice were 
generated that expressed membrane bound Hb(64-76) APLs in addition to endogenous 
peptides (78, 154, 183). These APL transgenic mice were used to identify the strength of 
selecting peptides in the thymus when crossed to the n3.L2 TCR transgenic mouse. The 
138 
same APL mice crossed to M2 would highlight differences in the selection of these two T 
cells. For instance, Q72, a null peptide in the periphery, enhanced positive selection of 
n3.L2 CD4 T cells whereas A72, an antagonist, induced negative selection and E72, 
another null peptide, had no effect (78). Given the pattern of APL activation in the 
periphery and with DP thymocytes, we would predict that M2 T cells might undergo 
negative selection by Q72 and potentially positive selection by E72. These transgenic 
mice would provide further insight into the relationship between affinity and selecting 
endogenous peptides. Interestingly, n3.L2 T cells that developed in the presence of A72 
failed to proliferate in vivo but did respond to wildtype Hb(64-76) ex vivo (154, 183). 
While this confirms the role of A72 as an antagonist for n3.L2, it suggests that induction 
of anergy in M2 T cells may reflect more than just an increased affinity for APLs. 
Interestingly, n3.L2 T cells that developed in the presence of I72, a weaker antagonist, 
failed to proliferate upon exposure to wildtype Hb(64-76) but did produce IL-2 (124), 
potentially mimicking the profile of M2 CD4 T cells. A selecting peptide does not have 
to be an antagonist to alter the responsiveness of T cells in the periphery. Selection by a 
weak agonist can decrease cytokine production and cytolytic activity by CD8 T cells in 
response to the selecting ligand (184). Therefore, the affinity of a TCR for pMHC in the 
thymus does fine tune T cell responsiveness in the periphery. Crossing the M2 transgenic 
mouse to the APL mice would provide a way to directly test whether antagonism in the 
thymus results in anergy or just further antagonism in the periphery. Should M2 T cells 
be anergic after selection by A72 or I72, the difference between n3.L2 and M2 T cells 
may be a consequence of signaling changes downstream of the TCR.  
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In addition to examining the amount and nature of selecting peptides, the 
signaling regulation between positive and negative selection has not been compared for 
n3.L2 and M2 thymocytes. The affinity threshold between a positively selecting and 
negatively selecting peptide is very small, only a 1.2 fold difference (67), but the 
accumulation of signals downstream of the TCR differs (185). Lck is thought to be 
present in a consitutively active state (186). Upon binding of the TCR, Lck is recruited to 
the TCR:pMHC complex via coreceptor engagement and then phosphorylates ITAMs on 
the CD3ζ chains. While CD4 T cells are less dependent on the coreceptor for enhancing 
activation (81), selection of M2 and n3.L2 T cells may differ as a result of changes in 
early signaling downstream of the TCR. Since negatively selecting peptides induce faster 
and higher accumulation of Lck (187), M2 may recruit more Lck following stimulation 
with self pMHC because of a faster kon. Higher levels of CD3ζ phosphorylation recruit 
high levels of ZAP-70 (188). As a consequence, the pattern of ZAP-70 phosphorylation 
changes, inducing negative selection due to enhanced activity (76). Interestingly, 
mutation of ZAP-70, inhibiting its activation, skews both positive and negative selection 
of T cells, resulting in failure to eliminate autoreactive T cells (189). Since development 
of M2 and n3.L2 was restricted in the Rag1-/- mice, the levels of ZAP-70 would not be 
decreased by expression of a secondary TCR. However, the fast kon for M2 binding 
pMHC may result in more or differential phosphorylation of ZAP-70, something that can 
easily be tested by western blot of thymocyte populations. The activation state of ZAP-70 
leads to a specific pattern of Ca2+ and ERK signaling, and pERK localization that results 
in negative selection (67). High levels of pERK are only induced with strong peptide 
stimulation. Isolated n3.L2 and M2 DP thymocytes can be imaged for Ca2+ flux using 
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Fura-2 AM, as was done with peripheral T cells. pERK can be measured in a flow 
cytometry assay using fluo-4 AM. The pattern of Ca2+ and pERK may give a clue as to 
how negative selection in the thymus sets anergy in peripheral T cells. Transient ERK 
phosphorylation may be regulated by the activation of Ras. Cellular and theoretical 
studies have identified that positively selecting ligands activate Ras by Ras-GRP (67, 87). 
When a high affinity TCR:pMHC interaction occurs, Ras can be activated by a second 
pathway through recruitment of Grb2/SOS to the plasma membrane. This creates a 
positive feedback loop, which increases the level of Ras-GTP above a threshold leading 
to negative selection. By comparing the levels and activation states of these signaling 
components in n3.L2 and M2, we can generate a signaling profile for T cells undergoing 
positive and negative selection. Additionally, we can compare the response of n3.L2 and 
M2 thymocytes to APLs to further characterize how changes in kinetic parameters, such 
as kon, alter signal transduction during T cell selection. The same profile could provide 
insight into how the signals leading to negative selection can alternatively induce anergy 
in T cells that escape deletion.  
 
Examination of signaling downstream of the TCR that leads to anergy induction and 
alteration of n3.L2 versus M2 responsiveness in the periphery 
Induction of anergy in a T cell has been shown to be dependent on the stability of the 
TCR:pMHC complex (128, 190) and may be induced in the absence of costimulation. 
The M2 affinity for Hb(64-76)/I-Ek indicates that a stable complex can be formed 
between soluble scTCR and pMHC complexes. Originally, the M2 TCR was selected for 
increased stability on the surface of yeast (137), lending further evidence against an 
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unstable TCR:pMHC complex. In vivo, there may be a difference in the stability of the 
TCR:pMHC complex that inhibits formation of the immune synapse and productive, 
sustained signaling (190). However, as the M2 Rag+/+ T cells do respond to antigen 
stimulation, complex instability is unlikely to be the cause of anergy induction in M2 
Rag1-/- T cells. The geometric shape of the synapse can augment signaling downstream of 
the TCR (191, 192). When TCR:pMHC complexes are restricted from forming the 
cSMAC, Ca2+ and tyrosine phosphorylation levels both were increased (191), though 
whether this leads to enhanced activation or, more likely, inhibition of T cell activation 
has not been determined. The formation of a synapse can be imaged with isolated n3.L2 
and M2 T cells on lipid bilayers containing pMHC, with and without the addition of 
costimulation, and may provide insight into how changes in the TCR:pMHC affinity 
affect clustering and downstream signaling (51). A difference in the level of 
costimulation also seems unlikely since n3.L2 and M2. T cells had equivalent levels of all 
costimulatory and inhibitory receptors measured. One thought would be that the levels of 
these molecules, such as CTLA-4, PD-1 or CD28, would change after activation 
(reviewed in (7)). Perhaps the anergic M2 T cells have a high proportion of CTLA-4 on 
the surface to outcompete CD28 and dampen costimulation. While this may be a simple 
explanation of the difference between n3.L2 and M2 T cells, the more intriguing 
possibility is that changes in intracellular signaling downstream of the TCRs control the 
propensity for tolerance. 
 Tolerance induction has been linked to phosphorylation of CD3ζ, ERK, ZAP-70, 
and formation of NFAT dimers (7, 128, 145, 179-181, 190, 193). Low levels of pZAP-70 
can disregulate levels of ERK and change the intracellular Ca2+ level. Since Ca2+ is a 
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critical second messenger in many signaling pathways, the level and characteristics of 
Ca2+ flux regulate diverse outcomes, including anergy. The n3.L2 and M2 T cells differ 
in intracellular Ca2+ pattern. As a consequence, n3.L2 and M2 T cells may differ in 
activation of NFAT, required for production of IL-2. The amplitude, duration and 
oscillations of intracellular Ca2+ activate specific sets of transcription factors leading to 
complex patterns of gene expression (178, 194, 195). Most likely this is through 
regulation of NFAT dimer formation (180) and the balance of activating NFAT versus 
NFκB (178, 195). The anergic M2 T cells had a more oscillatory signal that was lower 
than n3.L2’s sustained signal. Interestingly, NFAT activation requires rapid oscillations 
that result in a low, sustained level of intracellular Ca2+ (178, 179). In contrast, a large 
transient rise with infrequent oscillations preferentially stimulates NFκB. Perhaps the 
sustained Ca2+ level in n3.L2 T cells leads to transcription of NFAT dependent genes, 
including IL-2, and can account for the maintained responsive state of these T cells. In 
contrast, while M2 T cells have a more oscillatory phenotype, these oscillations are rather 
small and may not be enough to sustain NFAT transcription of IL-2. As a consequence, 
NFAT may form homodimers that inhibit association with AP-1 and lead to the 
activation of anergy-inducing genes (180, 181). It would be interesting to see if n3.L2 
and M2 CD4 T cells differ in activation of NFAT and NFκB. Since the initial Ca2+ 
studies were done in the absence of costimulation, the addition of CD28 ligands may alter 
the phenotype, providing evidence as to the importance of costimulation in sustained 
intracellular Ca2+ levels and production of IL-2.  
 A consequence of differential gene transcription is skewed production of 
cytokines. In a state of anergy, NFAT preferentially induces production of suppressive 
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cytokines, such as IL-10, though the level may differ in Th1 versus Th2 cells (181). 
Different cytokines are induced by subtle changes in secondary signal messengers, such 
as Ca2+, and have varying requirements for costimulation (113). Cytokine production by 
n3.L2 and M2 T cells was not examined aside from IL-2.  While n3.L2 was originally a 
Th1 clone, the stronger affinity M2 may produce a different cytokine profile upon 
activation by agonist peptides. If M2 favors suppressive signals, this would account for 
the development of an anergic Rag1-/- population and failure to sustain activation in 
Rag+/+ T cells. In addition to assaying cytokine production in vitro, measuring in vivo 
production in the Hbd Cα-/- transfer system may provide insight into the delayed disease 
induction by M2 CD4 T cells.  
 
Skewing of T cell differentiation and memory formation as a consequence of differences 
in T cell signaling 
 In addition to controlling cytokine production, levels of NFAT family members 
control the differentiation of naive T helper cells. NFATc2 and NFATc3 function to 
decrease T cell sensitivity to TCR stimulation. T cells deficient in NFATc2 and NFATc3 
preferentially develop into Th2 cells and secrete high levels of IL-4 (196). In contrast, 
NFATc promotes a T cell response by lowering the threshold for activation (197). When 
unchecked in the absence of suppressive NFAT factors, NFATc induces rampant 
production of Th2 cytokines, antibodies, and T cell resistance to Fas induced death (197). 
This skewing occurred both in vivo and in vitro by the cytokine milleu. In addition to 
being resistant to activation induced cell death, the T cells had a faster initiation of 
proliferation dependent on Ca2+ signaling (196). The early but unsustained proliferation 
144 
of M2 Rag+/+ CD4 T cells may also reflect faster signaling downstream of the TCR 
because of a lower activation threshold, potentially altering the function of these cells. 
Instead of TCR sequence, costimulatory signals regulate the differentiation of effector T 
cell populations (198). CD28 promotes and CTLA-4 inhibits generation of Th2 cells 
(199). The difference in intracellular Ca2+ signal between n3.L2 and M2 T cells may 
reflect a change in the propensity of these T cells to develop into effector populations, 
even though the original n3.L2 clone was a Th1 cell. As such, the responses of n3.L2 and 
M2 T cells to infection or autoantigen may differ.  
 The strength of the TCR contacting pMHC is critical for naive T cell homeostasis 
and the generation of memory T cell populations (200). Both processes are critical for 
maintaining protection against foreign infection. While n3.L2 and M2 CD4 T cells from 
unmanipulated transgenic mice did not differ in levels of IL-7R or CD44, the difference 
in sensitivity between n3.L2 and M2 TCRs may result in changes in long term survival of 
naive T cells or development of memory T cells. Interestingly, an eleveated level of Ca2+ 
from strong TCR signaling induces apoptosis, which can be blocked by Bcl-2, whereas 
low-level oscillations promote survival (201). Therefore the difference in Ca2+ flux 
measured between n3.L2 and M2 T cells may indicate a difference in survival. When the 
T cell population is small, the level of antiapoptotic IL-7 is increased, leading 
proliferation and differentiation into a memory population (202). Tracking the number of 
transgenic T cells in old M2 and n3.L2 mice could provide information on the 
homeostatic survival rate of the two different T cells, especially given the difference in 
thymus sizes at 8 weeks of age. Since isolated M2 T cells were anergic to ex vivo 
stimulation, it is unlikely that we would be able to monitor T cell proliferation in vivo. 
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Transfer of the M2 T cells to a lymphopenic host might induce homeostatic expansion 
due to increased levels of IL-7.  
 Since CD4 T cells undergo less homeostatic proliferation than CD8s, a better 
question may be to identify if an increased kon for pMHC binding alters generation of a 
memory population. We sought to use a Hb-expressing Listeria monocytogenes mutant to 
examine n3.L2 and M2 activation and recall response to an infection. However, we were 
unable to induce proliferation of either T cell to stimulation by infected macrophages in 
vitro or immunization in vivo. Presumably the system we used induced tolerance of both 
n3.L2 and M2 T cells. In the lymphopenic Hbd Cα-/- mice, both n3.L2 and M2 T cells 
seem to expand to fill the T cell niche and induce autoimmune disease, though the 
transferred cells were not characterized for phenotypic markers of activation or memory. 
Using the Hbd Cα-/- transfer system, we can identify how differences in the TCR:pMHC 
affinity alter the rates of T cell expansion or change the activation or memory state of 
CD4 T cells. The development of memory cells may reflect the affinity of naive T cells 
for self pMHC in the periphery, however the maintenance of this population is primarily 
due to cytokines (200, 203). The generation of effector memory cells, which have an 
activated phenotype, is dependent on the strength of TCR affinity for pMHC. The M2 
TCR may generate a larger or more sensitive effector memory population as a 
consequence of a higher affinity for pMHC. The altered memory population would 
confer better protection from secondary infection but also increase the possibility of 
responding to endogenous antigen (200, 203). 
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The correlation of TCR:pMHC kinetics to T cell selection and activation, and improving 
the measurement of this relationship  
 The affinity measurements presented in this thesis are derived from measurements 
of 3D kinetics using purified scTCR and pMHC molecules for SPR. While this system 
provides a way to make conclusions based on kinetic paramenters of the TCR:pMHC 
complex, 3D kinetic measurements may not accurately reflect in vivo interactions. Recent 
studies have suggested that 2D kinetics more accurately reflect in vivo activation 
phenotypes and have proposed this as a better system to generate conclusions as to how 
kinetics regulate T cell activation (25, 153). We are currently using 2D KD measurements 
to assess the affinity of TCR for selecting peptide and in a Listeria specific TCR system. 
Similar measurements could be obtained for n3.L2 and M2 and provide a stronger 
correlation between activation and kinetics. One caveat is that this may alter the 
conclusion that M2’s increased affinity for Hb(64-76)/I-Ek is due to a change in kon. 
However, in the original reports using the 2D KD system (153) and in reports using a 
FRET based system in vivo (41), the largest differences between 3D kinetics and these 
other methods are measured for kon, suggesting the relationship we reported for n3.L2 
versus M2 may be maintained, though with a different magnitude.  
 Even though large structural changes in the TCR:pMHC complex have not been 
observed with higher affinity TCRs (182), a fast kon may reflect optimized molecular 
conformations for clustering of TCR:pMHC molecules upon activation. Formation of 
clusters amplifies signals downstream of the TCR but is not required for effective 
activation of a T cell, including Ca2+ signaling (204). As the TCR:pMHC interaction is 
transient in vivo, a faster kon may alter serial engagement of a TCR or the formation of the 
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cSMAC, which detunes the level of activation (109). A consequence of an increased kon 
could then be strong signaling through the TCR leading to amplification of inhibitory 
signals and development of anergy (51), as seen for the M2 T cells. While the studies 
presented in this thesis suggest a definitive role for kon in regulating CD4 T cell selection 
and activation, additional systems examining changes solely in kon need to be generated 
to extend these studies to a general T cell population. By examining changes in the 
duration and structure of kon driven TCR:pMHC interactions and the propagation of 
signaling in the T cell, we can understand the sensitive regulation of T cell activation and 
uncover new ways to enhance, or inhibit, T cell mediated immunity.  
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